

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Hidradenitis suppurativa: an update on connecting... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1272/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1272" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Hidradenitis suppurativa: an update on connecting the tracts" />
    
            <meta name="og:title" content="F1000Research Article: Hidradenitis suppurativa: an update on connecting the tracts.">
            <meta name="og:description" content="Read the latest article version by Mallory K Smith, Cynthia L Nicholson, Angela Parks-Miller, Iltefat H Hamzavi, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12238">
            <meta name="article-id" content="11337">
            <meta name="dc.title" content="Hidradenitis suppurativa: an update on connecting the tracts">
            <meta name="dc.description" content="Hidradenitis suppurativa (HS) is a devastating disease involving abscesses, sinus tracts, and inflammation classically affecting the axilla, groin, and/or anogenital region. Although the disease pathogenesis is not fully understood, recent advances suggest that HS pathology runs much deeper than the cutaneous manifestations. It is now believed that HS is a systemic inflammatory disease that gives rise to the characteristic cutaneous manifestations. This disease is problematic for both patients and physicians to manage because of a variety of diagnostic and management difficulties. This article seeks to provide updates on the current understanding of HS to increase awareness and improve management.">
            <meta name="dc.subject" content="hidradenitis suppurativa, treatment, comorbidities, pathophysiology, mental health, sexual health, update">
            <meta name="dc.creator" content="Smith, Mallory K">
            <meta name="dc.creator" content="Nicholson, Cynthia L">
            <meta name="dc.creator" content="Parks-Miller, Angela">
            <meta name="dc.creator" content="Hamzavi, Iltefat H">
            <meta name="dc.date" content="2017/07/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11337.1">
            <meta name="dc.source" content="F1000Research 2017 6:1272">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="hidradenitis suppurativa ">
            <meta name="prism.keyword" content=" treatment ">
            <meta name="prism.keyword" content=" comorbidities ">
            <meta name="prism.keyword" content=" pathophysiology ">
            <meta name="prism.keyword" content=" mental health ">
            <meta name="prism.keyword" content=" sexual health ">
            <meta name="prism.keyword" content=" update">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/07/28">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1272">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11337.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1272">
            <meta name="citation_title" content="Hidradenitis suppurativa: an update on connecting the tracts">
            <meta name="citation_abstract" content="Hidradenitis suppurativa (HS) is a devastating disease involving abscesses, sinus tracts, and inflammation classically affecting the axilla, groin, and/or anogenital region. Although the disease pathogenesis is not fully understood, recent advances suggest that HS pathology runs much deeper than the cutaneous manifestations. It is now believed that HS is a systemic inflammatory disease that gives rise to the characteristic cutaneous manifestations. This disease is problematic for both patients and physicians to manage because of a variety of diagnostic and management difficulties. This article seeks to provide updates on the current understanding of HS to increase awareness and improve management.">
            <meta name="citation_description" content="Hidradenitis suppurativa (HS) is a devastating disease involving abscesses, sinus tracts, and inflammation classically affecting the axilla, groin, and/or anogenital region. Although the disease pathogenesis is not fully understood, recent advances suggest that HS pathology runs much deeper than the cutaneous manifestations. It is now believed that HS is a systemic inflammatory disease that gives rise to the characteristic cutaneous manifestations. This disease is problematic for both patients and physicians to manage because of a variety of diagnostic and management difficulties. This article seeks to provide updates on the current understanding of HS to increase awareness and improve management.">
            <meta name="citation_keywords" content="hidradenitis suppurativa, treatment, comorbidities, pathophysiology, mental health, sexual health, update">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Mallory K Smith">
            <meta name="citation_author_institution" content="Wayne State University School of Medicine, Detroit, MI, USA">
            <meta name="citation_author" content="Cynthia L Nicholson">
            <meta name="citation_author_institution" content="Henry Ford Hospital Department of Dermatology, Detroit, MI, USA">
            <meta name="citation_author" content="Angela Parks-Miller">
            <meta name="citation_author_institution" content="Henry Ford Hospital Department of Dermatology, Detroit, MI, USA">
            <meta name="citation_author" content="Iltefat H Hamzavi">
            <meta name="citation_author_institution" content="Henry Ford Hospital Department of Dermatology, Detroit, MI, USA">
            <meta name="citation_publication_date" content="2017/07/28">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1272">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11337.1">
            <meta name="citation_firstpage" content="1272">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1272/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1272.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12238 /> <input type=hidden id=articleId name=articleId value=11337 /> <input type=hidden id=xmlUrl value="/articles/6-1272/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1272-v1.xml"> <input type=hidden id=article_uuid value=6bd3d3d1-1fe1-4038-aebd-569b6ef2d94b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Hidradenitis suppurativa: an update on connecting the tracts"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11337.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11337.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1272"
  },
  "headline": "Hidradenitis suppurativa: an update on connecting the tracts",
  "datePublished": "2017-07-28T14:48:47",
  "dateModified": "2017-07-28T14:48:47",
  "author": [
    {
      "@type": "Person",
      "name": "Mallory K Smith"
    },    {
      "@type": "Person",
      "name": "Cynthia L Nicholson"
    },    {
      "@type": "Person",
      "name": "Angela Parks-Miller"
    },    {
      "@type": "Person",
      "name": "Iltefat H Hamzavi"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Hidradenitis suppurativa (HS) is a devastating disease involving abscesses, sinus tracts, and inflammation classically affecting the axilla, groin, and/or anogenital region. Although the disease pathogenesis is not fully understood, recent advances suggest that HS pathology runs much deeper than the cutaneous manifestations. It is now believed that HS is a systemic inflammatory disease that gives rise to the characteristic cutaneous manifestations. This disease is problematic for both patients and physicians to manage because of a variety of diagnostic and management difficulties. This article seeks to provide updates on the current understanding of HS to increase awareness and improve management."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1272/v1",
            "name": "Hidradenitis suppurativa: an update on connecting the tracts"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Hidradenitis suppurativa: an update on connecting the tracts </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12238 data-id=11337 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11337.1" data-recommended="" data-doi="10.12688/f1000research.11337.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1272/v1/pdf?article_uuid=6bd3d3d1-1fe1-4038-aebd-569b6ef2d94b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11337-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11337-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11337-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Smith MK, Nicholson CL, Parks-Miller A and Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1272 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11337.1" target=_blank>https://doi.org/10.12688/f1000research.11337.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11337-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11337 id=track-article-signin-11337 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11337?target=/articles/6-1272/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12238 /> <input name=articleId type=hidden value=11337 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Hidradenitis suppurativa: an update on connecting the tracts</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Mallory K Smith<sup>1</sup>,&nbsp;</span><span class="">Cynthia L Nicholson<sup>2</sup>,&nbsp;</span><span class="">Angela Parks-Miller<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:ihamzav1@hfhs.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Iltefat H Hamzavi</span></a><a href="https://orcid.org/0000-0002-3137-5601" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3137-5601</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Mallory K Smith<sup>1</sup>,&nbsp;</span><span class="">Cynthia L Nicholson<sup>2</sup>,&nbsp;</span><span class="">Angela Parks-Miller<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:ihamzav1@hfhs.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Iltefat H Hamzavi</span></a><a href="http://orcid.org/0000-0002-3137-5601" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3137-5601</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Jul 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11337.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Wayne State University School of Medicine, Detroit, MI, USA<br/> <sup>2</sup> Henry Ford Hospital Department of Dermatology, Detroit, MI, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=24394-24624></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23057-22888></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=24395-24625></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Hidradenitis suppurativa (HS) is a devastating disease involving abscesses, sinus tracts, and inflammation classically affecting the axilla, groin, and/or anogenital region. Although the disease pathogenesis is not fully understood, recent advances suggest that HS pathology runs much deeper than the cutaneous manifestations. It is now believed that HS is a systemic inflammatory disease that gives rise to the characteristic cutaneous manifestations. This disease is problematic for both patients and physicians to manage because of a variety of diagnostic and management difficulties. This article seeks to provide updates on the current understanding of HS to increase awareness and improve management. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> hidradenitis suppurativa, treatment, comorbidities, pathophysiology, mental health, sexual health, update </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Iltefat H Hamzavi (<a href="mailto:ihamzav1@hfhs.org">ihamzav1@hfhs.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Iltefat H Hamzavi </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Iltefat Hamzavi is the current president of the Hidradenitis Suppurativa Foundation (non-funded) and was an investigator for AbbVie. Angela Miller has served on an advisory board and as a consultant for AbbVie and is an employee of the Hidradenitis Suppurativa Foundation. Cynthia Nicholson and Mallory Smith declare that they do not have any competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Smith MK <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Smith MK, Nicholson CL, Parks-Miller A and Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1272 (<a href="https://doi.org/10.12688/f1000research.11337.1" target=_blank>https://doi.org/10.12688/f1000research.11337.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Jul 2017, <b>6</b>(F1000 Faculty Rev):1272 (<a href="https://doi.org/10.12688/f1000research.11337.1" target=_blank>https://doi.org/10.12688/f1000research.11337.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Jul 2017, <b>6</b>(F1000 Faculty Rev):1272 (<a href="https://doi.org/10.12688/f1000research.11337.1" target=_blank>https://doi.org/10.12688/f1000research.11337.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e198>Introduction</h2><p class="" id=d28013e201>Hidradenitis suppurativa (HS) is an inflammatory disease characterized by recurrent, painful abscesses and fistulous tracts<sup><a href="#ref-1">1</a></sup>. Patients with HS objectively have one of the lowest quality of life measures of any dermatologic disease<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Lesions characteristically occur in the axillary, groin, inframammary, and/or anogenital regions of the body, although other sites may be involved<sup><a href="#ref-4">4</a></sup>. HS lesions may progress to form sinus tracts and expansive abscesses. Sequelae include significant pain, scarring, and psychological distress<sup><a href="#ref-5">5</a></sup>. This article provides a comprehensive update on the current understanding of HS while also expanding upon the 2014 publication “Update on hidradenitis suppurativa: connecting the tracts” by Gill <i>et al.</i><sup><a href="#ref-1">1</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e232>Background</h2><div class=section><a name=d28013e235 class=n-a></a><h3 class=section-title>Epidemiology</h3><p class="" id=d28013e240>HS was first described in 1839 by Velpeau in France<sup><a href="#ref-1">1</a></sup>. Since that time, and specifically throughout the past 10–20 years, much has been learned about this disease.</p><p class="" id=d28013e247>The average age of onset is during the early 20s, although pediatric cases are not uncommon. HS is more common in females than in males, at a rate of approximately 3:1. Additionally, HS more commonly occurs in the African-American population<sup><a href="#ref-6">6</a>–<a href="#ref-9">9</a></sup>. A recent retrospective study discovered significantly elevated rates of HS in African-American patients compared to Caucasian patients (6.4% to 3.9%, respectively), although further evidence is needed to support this association<sup><a href="#ref-9">9</a></sup>.</p><p class="" id=d28013e261>The prevalence of HS is a controversial topic, reported between 0.00033 and 4.1%, although underdiagnosis or improper diagnosis is common<sup><a href="#ref-10">10</a></sup>. A study from 1996 by Jemec <i>et al</i>. assessed 507 individuals undergoing sexually transmitted disease screening and calculated a point prevalence of 4.1% and a 1-year prevalence of 1.0%<sup><a href="#ref-11">11</a></sup>. In 2008, Revuz <i>et al</i>. carried out two case-control studies to explore HS prevalence, which was determined to be 1%<sup><a href="#ref-12">12</a></sup>. In 2013, the prevalence of HS in a health insured-only population (n = 7,927) was found to be 0.053%<sup><a href="#ref-13">13</a></sup>. In continuation, in 2014, a population-based study in Olmsted County, Minnesota, reviewed medical records from 1968–2008 and reported a prevalence of 0.13%. This study also indicated that the prevalence of HS is increasing, with rates of 4.3 per 100,000 between 1970 and 1979 to 9.6 per 100,000 between 2000 and 2008<sup><a href="#ref-14">14</a></sup>. This study estimated a lower prevalence, although these findings are limited because this population’s racial and ethnic distribution was not representative of the United States. Another cross-sectional population study in Denmark evaluated HS demographics, and, overall, inverse recurrent suppuration (probable HS) prevalence was 2.1% based on a self-administered questionnaire given to adults aged 30–89<sup><a href="#ref-15">15</a></sup>.</p><p class="" id=d28013e295>Overall, HS prevalence varies significantly based on study methodology; however, the disease appears to be more common than was previously considered.</p></div><div class=section><a name=d28013e299 class=n-a></a><h3 class=section-title>Exacerbating factors</h3><p class="" id=d28013e304>Exacerbating factors of HS include, but are not limited to, mechanical stressors such as friction from clothing, sweating, and shaving<sup><a href="#ref-16">16</a></sup>. Of interest is the role of diet in the exacerbation or progression of disease. Owing to the possible role of hormonal regulation in disease pathogenesis, dairy was studied, as it may elevate insulin and promote androgen stimulation through the theorized hormonal effects of casein, whey, simple sugars, and 5-α reduced dihydrotestosterone (DHT). Forty-seven patients were placed on a dairy-free diet, and 83% clinically improved, while none experienced worsening of disease, compared to the control population that did not follow the dairy-free diet<sup><a href="#ref-17">17</a></sup>. This study reported impressive improvement; however, it failed to utilize validated assessment methods, and recall and non-response bias may have contributed to the outcome.</p><p class="" id=d28013e315>Brewer’s yeast is another dietary component of interest. One study followed 12 patients who eliminated foods containing brewer’s yeast, such as breads, beer, black tea, fermented cheese, and more, after the completion of HS surgery. Stabilization and eventual regression of HS throughout the one-year study period was reported<sup><a href="#ref-18">18</a></sup>. However, because of the small sample size, future studies are needed to further elucidate the role of brewer’s yeast in HS management.</p><p class="" id=d28013e322>In the authors’ experience, some patients report dietary triggers, while others report that strict adherence to various diets results in no change in symptoms, suggesting that further evidence is needed to evaluate this relationship. Nonetheless, the role of diet in HS disease management is a topic of great interest in both the general and the scientific communities.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e329>Associations and comorbidities</h2><p class="" id=d28013e332>Obesity and cigarette smoking have known associations with HS<sup><a href="#ref-12">12</a>,<a href="#ref-19">19</a></sup>. A recent retrospective questionnaire reported that the prevalence of HS in an obese population was 18.1%, significantly higher than the general population. Additionally, 35% of these subjects reported improvement in HS symptoms following bariatric surgery and subsequent weight loss<sup><a href="#ref-8">8</a></sup>. Miller <i>et al</i>. observed body composition and basal metabolic rate in a cross-sectional study and determined that hospitalized HS patients had significantly higher body fat, visceral fat, BMI, waist circumference, and waist/hip ratio, while muscle and bone mass percentages were significantly lower than in controls<sup><a href="#ref-20">20</a></sup>. Additional comorbidities have been elucidated based on a case-control analysis of 2,292 HS patients, which found that arthropathies, obesity, dyslipidemia, hormonal disease such as polycystic ovarian syndrome, psychiatric disorders, drug or alcohol dependence, cardiovascular disease, and thyroid aberrancies occur more commonly in those with HS<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d28013e357>HS is also associated with metabolic syndrome, a multifaceted disease state including diabetes mellitus/insulin resistance, hypertension, dyslipidemia, and obesity. The prevalence of metabolic syndrome in HS patients was significantly higher than in controls in a retrospective chart review, at a rate of 50.6% compared to 30.2%, respectively<sup><a href="#ref-22">22</a></sup>. Other studies have supported this association, specifically regarding increased prevalence of obesity, hypertriglyceridemia, and insulin resistance in HS patients<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>.</p><p class="" id=d28013e371>Metabolic disease increases the risk of cardiovascular disease, a major health concern because of the associated increases in morbidity and mortality<sup><a href="#ref-22">22</a></sup>. Patients with HS are significantly more likely to have atherosclerotic disease than are controls, particularly carotid artery atherosclerosis, as determined through ultrasonography. Although causation was not determined, it was theorized that systemic inflammation associated with HS promoted atherosclerosis<sup><a href="#ref-24">24</a></sup>. This finding is concerning because cardiovascular disease is often subclinical and asymptomatic, with potentially deadly consequences. It has also been hypothesized that elevated levels of the inflammatory molecules interleukin (IL)-17 and tumor necrosis factor (TNF)-α contribute to endothelial damage. This provides immunologic context to relate cardiovascular disease to HS<sup><a href="#ref-25">25</a></sup>. The risk of cardiovascular events in patients with HS was also assessed in a Danish population-based cohort study of 5,964 subjects using data collected between 1997 and 2011. Compared to controls, HS patients were at an increased risk for ischemic stroke, cardiovascular-related mechanisms of death, major adverse cardiac events, and, surprisingly, all-cause mortality<sup><a href="#ref-26">26</a></sup>. These studies provide valuable knowledge for healthcare providers in all fields of medicine, which should guide preventative screening and interventions, along with public health research.</p><p class="" id=d28013e390>Chronic inflammatory diseases, such as inflammatory bowel disease (IBD), are also associated with HS<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. The prevalence of IBD in 7,732 HS patients was 0.8%, significantly higher than the reported prevalence of IBD in the general population, at 0.3%. Additionally, the risk of new-onset IBD was significantly elevated in HS patients, specifically Crohn’s disease (CD), with a hazard risk of 2.19, and ulcerative colitis (UC), with a hazard risk of 1.63<sup><a href="#ref-26">29</a></sup>. Another recent multicenter cross-sectional study indicated that the prevalence of IBD with HS was 3.3%; of that, 2.5% was CD and 0.8% was UC. Compared to the prevalence of IBD in the general Northern European population (0.41–0.74%), the prevalence of IBD was much higher in HS patients<sup><a href="#ref-30">30</a></sup>. Another recent population-based cohort study in Minnesota observed the rates of HS in 679 patients with IBD. The 10-year incidence of HS was 0.85%, and the 30-year incidence was 1.55%. Overall, patients with IBD were nine times more likely to develop HS compared to the general population<sup><a href="#ref-31">31</a></sup>. CD exhibits many parallels with HS, as both are chronic epithelial inflammatory diseases with inhabitation of bacterial flora, have a genetic predisposition, and respond to similar medication classes<sup><a href="#ref-28">28</a></sup>.</p><p class="" id=d28013e417>Owing to the chronic inflammation inflicted by recurrent HS lesions, squamous cell carcinoma (SCC) is a rare but serious complication of longstanding disease, with an incidence of 0.5–4.6% over the course of the disease<sup><a href="#ref-27">27</a>,<a href="#ref-32">32</a></sup>. It is hypothesized that free radical production and subsequent DNA damage provides the appropriate environment for malignant transformation, particularly in perianal regions of HS involvement<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. It is unknown if systemic inflammation from HS itself contributes to the increased risk. Of great concern, high-risk human papilloma virus (HPV) type 16 has been isolated in pathology specimens of SCC lesions in HS patients<sup><a href="#ref-35">35</a></sup>. These associations are important for healthcare providers, as HPV testing and biopsy of a suspicious lesion with subsequent early intervention is associated with improved prognosis. Risk of malignancy is also an important consideration when beginning a biologic medication, which is associated with immunosuppression.</p><p class="" id=d28013e438>Psychiatric diseases, specifically anxiety and depression, are associated with HS, and this is discussed in further detail in the “Psychosocial impact” section<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>. Another notable association with HS is low socioeconomic status, as determined by a recent cross-sectional study by Deckers <i>et al</i>. The socioeconomic status of over 1,000 patients with HS was significantly lower than that of over 2,000 matched dermatologic controls. However, it is difficult to draw conclusions if downward drift is contributing to the socioeconomic status, as there are numerous confounding factors<sup><a href="#ref-38">38</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e458>Pathophysiology</h2><p class="" id=d28013e461>The pathophysiology of HS is not fully understood, although it is thought to be multifactorial. The disease is now believed to be a systemic inflammatory condition, contrary to previous hypotheses classifying HS as a purely cutaneous disorder.</p><div class=section><a name=d28013e464 class=n-a></a><h3 class=section-title>Genetics</h3><p class="" id=d28013e469>Both familial and sporadic cases of HS have been reported. It is thought that approximately 33% of HS cases are familial. Genetic variants of HS are heterogeneous, with several mutations identified throughout the genome, lacking a consistent genotype to phenotype correlation<sup><a href="#ref-39">39</a>–<a href="#ref-41">41</a></sup>. One study of 53 Chinese patients hypothesized to have familial HS were found to have a unique phenotype consisting of an increased male prevalence, earlier onset, and more severe disease involving atypical regions such as the neck and back<sup><a href="#ref-42">42</a></sup>. Because of the phenotypic variance in HS, Canoui-Poitrine <i>et al</i>. attempted to develop distinct phenotype-based subtypes of the disease, including axillary-mammary, follicular, and gluteal types. However, genetic analyses have not yet correlated with this grouping technique<sup><a href="#ref-43">43</a></sup>. Additionally, the specific phenotype “hidradenitis suppurativa fulminans” has been proposed to describe a specific, severe presentation of the disease<sup><a href="#ref-40">40</a></sup>. Phenotypic categorization will assist in future studies and determining a greater understanding of the varying presentations and genetics of this disease.</p><p class="" id=d28013e494>Some cases of HS are associated with syndromes, including pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome, related to mutations in proline-serine-threonine-phosphatase protein 1 (PSTPIP1). This gene is involved in the regulation of the inflammasome complex, a series of proteins and signaling pathways the body utilizes in response to inflammation-inducing stimuli<sup><a href="#ref-44">44</a></sup>. Another similar syndrome, pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH) syndrome, is also associated with PSTPIP1 gene mutations<sup><a href="#ref-45">45</a></sup>. Similarly, synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome has been associated with cases of HS. These relationships between HS and other auto-inflammatory diseases have bolstered the theory that HS may be auto-inflammatory in nature<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d28013e509>There is also evidence to support a relationship between familial HS and loss-of-function mutations in γ-secretase proteins, such as presenilin-1, presenilin enhancer-2, anterior pharynx defective 1, and nicastrin (NCSTN). These mutations were noted in variants of HS involving atypical regions such as the thighs and trunk<sup><a href="#ref-7">7</a>,<a href="#ref-47">47</a></sup>. The protease γ-secretase plays a role in the regulation of the canonical Notch signaling pathway, which is relevant to HS because Notch functions in the development of hair follicles, and as an immunomodulator in T-cell-mediated cellular immune responses. Inherited or acquired alterations in Notch signaling may play a pivotal role in HS disease pathogenesis<sup><a href="#ref-48">48</a></sup>. Cigarette smoking has been shown to decrease the activity of the Notch signaling pathway, further strengthening this association. Of note, having one of the above mutations does not guarantee disease development or progression<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d28013e527>Further, Xiao <i>et al</i>. analyzed the gene encoding NCSTN (<i>NCSTN</i>) in a human keratinocyte cell line and found that <i>NCSTN</i> knockdown cells exhibited impaired γ-secretase activity, leading to more rapid proliferation and a greater proportion of cells in the S-phase of the cell cycle. This study bolstered the theory that a deficiency in the NCSTN gene in familial forms of HS may play a role in abnormal keratinocyte growth and proliferation<sup><a href="#ref-50">50</a></sup>. Interestingly, Duchatelet <i>et al</i>. discovered a NCSTN mutation in a patient with PASH syndrome, interrelating genetic and auto-inflammatory hypotheses of the pathogenesis of HS<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d28013e552>Finally, a retrospective study by Deckers <i>et al</i>. evaluated trends in early onset HS, defined as disease onset before age 13. A family history of HS was a significant factor in the diagnosis of early onset HS as well as more widespread disease. There were no reported differences in comorbidities in patients with early onset disease compared to controls with normal-onset HS<sup><a href="#ref-52">52</a></sup>.</p></div><div class=section><a name=d28013e563 class=n-a></a><h3 class=section-title>Etiology</h3><p class="" id=d28013e568>Many previously accepted models of HS pathogenesis are being challenged. It is now believed that HS is a systemic inflammatory disease of multifactorial basis, possibly due to auto-inflammation<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d28013e575>It was formerly hypothesized that the disease originated in apocrine-bearing locations of the body, such as the groin and anogenital and axillary regions. However, the inframammary region, neck, trunk, and thighs are frequently involved as well<sup><a href="#ref-7">7</a></sup>. These areas experience recurrent friction, perhaps supporting the role of mechanical stress in the development of disease. Additionally, it was previously theorized that the first step in HS disease progression was the occlusion of the follicular infundibulum due to hyperkeratosis of adjacent epithelium. This hyperkeratosis was thought to act as a nidus for secondary infection, which caused the subsequent massive local inflammation associated with classic HS lesions<sup><a href="#ref-48">48</a>,<a href="#ref-54">54</a></sup>. Although follicular occlusion is paramount in the manifestations of HS, the instigating mechanism of occlusion is controversial. It has been hypothesized that these inflammatory events are instead secondary to an underlying aberrant inflammatory state in patients with HS instead of the primary cause of the disease<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d28013e593>Although the driving force behind the development of HS lesions is unknown, recent studies have proposed various theories to describe the instigating pathology. One study observed the basement membrane of lesional and clinically uninvolved skin and found abnormal epithelial support and basement membrane surrounding the follicular junction in lesional tissue based on periodic acid-Schiff (PAS) histologic staining. These findings suggested that individuals with HS may have an underlying anatomic defect in the basement membrane predisposing to secondary infections<sup><a href="#ref-56">56</a></sup>. Blok <i>et al</i>. similarly evaluated perilesional biopsies in patients with HS compared to healthy controls. Contrary to the previous findings, this study found neither a significant difference in PAS staining nor a difference in many other basement membrane constituents between patients and controls. However, this study observed significant upregulation of integrins α6 and β4 (signaling molecules with adhesive properties) within the sebaceous gland of HS patients compared to controls. The role of these integrins in HS is unclear at this time<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d28013e607>Additionally, it is known that keratinocytes and neutrophils play a role in the secretion of pro-inflammatory molecules in HS<sup><a href="#ref-58">58</a></sup>. Hotz <i>et al</i>. proposed that abnormal keratinocyte function plays a role in HS development. Compared to controls, keratinocytes in HS lesions showed a diminished inflammatory response to muramyl dipeptide, a pathogen-associated molecular pattern (PAMP) inflammatory antigen<sup><a href="#ref-59">59</a></sup>. Keratinocyte malfunction further suggests structural and molecular abnormalities allowing for follicular occlusion and disease progression. Although the precise cause of the follicular occlusion remains debated, cellular markers and other immunologic sources of inflammation are important topics of discussion in the ongoing search to determine the etiology of HS.</p><p class="" id=d28013e622>In summary, overarching themes of inflammation and abnormal cellular activity appear to provide the appropriate environment for the progression to HS clinical features. It is probable that many factors allow for altered cellular barrier mechanisms and anomalous secretion of pro-inflammatory cytokines in the progression to classic HS symptoms<sup><a href="#ref-48">48</a></sup>.</p></div><div class=section><a name=d28013e630 class=n-a></a><h3 class=section-title>Inflammation in hidradenitis suppurativa</h3><p class="" id=d28013e635>HS is a systemic inflammatory disease, and auto-inflammation is suggested to play a role in disease pathogenesis. This theory was bolstered by the association of comorbid autoimmune and inflammatory diseases, abnormal biochemical findings, and an infiltration of innate and adaptive immune cells within both lesional and perilesional skin before clinical manifestations of the disease arise<sup><a href="#ref-60">60</a></sup>. In particular, auto-inflammatory diseases (AIDs) are rare, hereditary, unprovoked systemic inflammatory diseases that classically occur in the absence of infection or autoantibodies. These disorders are thought to be due to altered regulation and signaling patterns in the innate immune system. As described above, HS has been associated with many AIDs<sup><a href="#ref-53">53</a>,<a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>.</p><p class="" id=d28013e652>The exact cytokine profile of HS has yet to be determined, although abnormal levels of several inflammatory cytokines have been observed in HS, with notable elevations in IL-1β, IL-10, IL-11, IL-17A, and CXCL9 (monokine induced interferon [IFN]-γ). Additionally, mRNA and protein quantities of TNF-α, IL-1β, and IL-10 were reportedly elevated in HS<sup><a href="#ref-63">63</a>–<a href="#ref-65">65</a></sup>. Interleukins are a part of the body’s natural response to stressors, secreted by innate and adaptive immune cells, each with its own specific role in immunomodulation. It is important to note that individual cytokine profiles differ between patients<sup><a href="#ref-66">66</a></sup>. While an in-depth discussion of the abnormal cytokine profile in HS is beyond the scope of this review, notable findings and common cytokine trends associated with HS will be expanded upon.</p><p class="" id=d28013e666>Increased activity of the pro-inflammatory IL-23/Th17 pathway has been implicated in many chronic inflammatory diseases, recently including HS. Studies have supported that IL-12 and IL-23 were expressed in large quantities by macrophages in HS lesional skin, along with the infiltration of IL-17-producing helper-T and CD4<sup>+</sup> T cells<sup><a href="#ref-65">65</a>,<a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>. IL-17-producing cells were similarly found in lesional and perilesional skin in HS patients. The knowledge of IL-17 as an activator of keratinocytes and source of inflammatory modulators in HS has provided important insights into the disease process as well as potential management options<sup><a href="#ref-25">25</a>,<a href="#ref-58">58</a>,<a href="#ref-69">69</a></sup>. These findings have important implications in the management of HS as ustekinumab, a monoclonal antibody against IL-23 and IL-12, has demonstrated some efficacy for HS management<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d28013e696>IL-1β is another pro-inflammatory cytokine elevated in lesional HS tissue<sup><a href="#ref-63">63</a></sup>. This cytokine is well known as a pyrogen and leukocyte-activating factor, among numerous other functions. A controlled clinical trial by Tzanetakou <i>et al</i>. determined that HS disease activity and exacerbations were attenuated with anakinra therapy. Anakinra is an antagonist of the IL-1 receptor, making the IL-1 pathway a reasonable target to pursue for disease management. Additionally, during the course of treatment with anakinra, the treatment group also exhibited decreased levels of other pro-inflammatory markers such as IL-6, TNF, and IFN-γ compared to controls, further supporting the role of the IL-1 pathway in HS pathogenesis<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d28013e711>IL-6 is another pro-inflammatory molecule of interest. This cytokine is elevated in inflammatory diseases such as rheumatoid arthritis, CD, and HS. Levels of IL-6 were significantly elevated in lesional HS tissue compared to controls in a recent study by Xu <i>et al</i>.<sup><a href="#ref-72">72</a></sup>. Interestingly, increased levels of IL-6 and C-reactive protein (CRP) were found to confer a poor response to infliximab treatment, making these markers reasonable adjunctive assessments in determining appropriate management<sup><a href="#ref-73">73</a></sup>. Further studies are needed to fully elucidate the role of IL-6 and methods to appropriately manage patients using this biochemical pathway.</p><p class="" id=d28013e725>Increased levels of chemotactic agents such as B-lymphocyte chemoattractant (BLC), CCL3, CCL5, and IL-16 have also been observed with HS<sup><a href="#ref-63">63</a>,<a href="#ref-74">74</a></sup>. These cytokines similarly play a role in inflammation, particularly the acute-phase reaction<sup><a href="#ref-60">60</a></sup>. Interestingly, markers such as IL-2, IL-4, IL-5, and IFN-γ were found to be extremely low in perilesional HS skin<sup><a href="#ref-63">63</a></sup>.</p><p class="" id=d28013e743>TNF-α is secreted by both innate and adaptive immune cells and has been implicated in the disease process of many other inflammatory conditions, such as psoriasis and inflammatory bowel disease. These findings have been instrumental in the development of biologic medications and led to the first approved biologic medication for HS, adalimumab<sup><a href="#ref-75">75</a></sup>. TNF-α has been shown to be elevated in HS through numerous studies, indicating important involvement in the disease pathogenesis, and as an effective target for management<sup><a href="#ref-64">64</a>,<a href="#ref-74">74</a></sup>.</p><p class="" id=d28013e757>Of note was the finding that levels of IL-1β, TNF-α, and IL-10 correlated with increased severity of HS, further supporting these markers as suitable targets for therapy<sup><a href="#ref-63">63</a>,<a href="#ref-65">65</a>,<a href="#ref-74">74</a></sup>. Following this work, Hotz <i>et al</i>. observed increased levels of CD4<sup>+</sup> T cells in patients with HS and increased levels of IL-17 and IFN-γ from the aforementioned T cells<sup><a href="#ref-59">59</a></sup>. Another study observed cytokine concentrations in purulent drainage obtained from HS lesions and found that, overall, pro-inflammatory cytokines such as TNF-α, IL-1β, IL-1α, and IL-17 were increased in addition to elevations in anti-inflammatory cytokines IL-10 and IL-1ra, although each patient exhibited a unique cytokine profile. This multifaceted study also provided evidence that peripheral blood monocytes in HS patients produced fewer cytokines and were less active in responding to stimulation than were controls, indicating systemic involvement in the disease<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d28013e784>Antimicrobial peptides (AMPs), such as β-defensin (BD) 1, BD2, BD3, and other S100 proteins, such as psoriasin and calgranulins A and B, are believed to play a role in the pathogenesis of HS. AMPs are natural defense molecules constitutively expressed by keratinocytes, although irritants and other inflammatory stimulators can modify their expression. Tissue samples from six HS patients exhibited overexpression of AMPs compared to skin from healthy controls<sup><a href="#ref-76">76</a></sup>. Interestingly, a similar study of seven patients evaluated AMPs and cytokines within HS lesions and found a relative decrease in all analyzed AMPs. It was thought that the decrease in AMPs contributed to the susceptibility to secondary infections. This study also provided evidence that a deficiency of IL-22 and IL-20 may be responsible for decreased AMP levels, although further studies are needed on this topic<sup><a href="#ref-77">77</a></sup>.</p><p class="" id=d28013e795>From a different molecular perspective, microRNAs (miRNAs) are short, non-coding nucleotide chains involved in gene regulation. miRNAs are thought to regulate inflammatory markers in many chronic inflammatory diseases, such as psoriasis. In 2016, Hessam <i>et al</i>. observed that the miRNA modulators Drosha and DGRC8 were significantly downregulated in perilesional HS tissue, although no change was observed in these markers in lesional tissue<sup><a href="#ref-78">78</a></sup>. Following this work, Hessam <i>et al</i>. evaluated levels of specific miRNA molecules. Interestingly, significant overexpression of several miRNAs was observed in lesional compared to healthy control skin, including miRNA-31 and miRNA-125b. Of note, miRNA-31 is thought to be involved in regulating skin inflammation, and miRNA-125b is proposed as an important regulator of keratinocyte proliferation and TNF-α production<sup><a href="#ref-79">79</a></sup>. Although further studies are needed to fully assess the dysregulation of miRNA in HS, these findings contributed to the understanding of the HS disease process at the molecular level.</p><p class="" id=d28013e813>This information, which will surely be supplemented by future studies, has provided the basis of knowledge for understanding HS as an inflammatory disease and supported the use of biologics in its management.</p></div><div class=section><a name=d28013e818 class=n-a></a><h3 class=section-title>Bacterial infection and biofilms</h3><p class="" id=d28013e823>The normal bacterial flora count of the skin is approximately 1 trillion microorganisms existing in a symbiotic state with the human body. The skin hosts a variety of microbiomes, with each body part creating a specialized topographic niche for different microorganisms. Most exist in harmony with the body, although imbalances have been observed in disease processes<sup><a href="#ref-80">80</a></sup>. In HS, bacterial colonization develops, causing suppurating lesions, although the exact role of microorganisms in disease pathogenesis is unknown. The immune response to the bacteria is likely abnormal, resulting in difficult-to-treat lesions.</p><p class="" id=d28013e830>Most HS lesions are poly-microbial in nature. The most frequently cultured bacteria from HS lesions are Gram-positive cocci and rods, such as coagulase-negative <i>Staphlococci</i> and <i>Corynebacterium</i>, as well as various subspecies of anaerobic bacteria<sup><a href="#ref-81">81</a></sup>. One study of recalcitrant HS observed that the most commonly cultured organisms were <i>Corynebacterium</i> species (14.0%), <i>Staphylococcus epidermidis</i> (13.1%), and <i>Staphylococcus aureus</i> (10.4%)<sup><a href="#ref-82">82</a></sup>. Interestingly, Jahns <i>et al</i>. evaluated 27 samples of HS lesional tissue and did not find <i>S. aureus</i> in any of the assessed samples. Of note, this was a retrospective analysis of fixed tissue using immunofluorescent labeling of samples that were not controlled for lesional depth. The absence of <i>S. aureus</i> was thought to be due to the anaerobic nature within deep HS lesions, contributing to the understanding that the identification of bacterial species is likely lesional depth dependent<sup><a href="#ref-83">83</a></sup>. It is likely that sample depth and methods of organismal assessment played a role in this finding. Guet-Revillet carried out a prospective study using a series of bacterial cultures from 102 HS lesions and determined that <i>S. lugdunensis</i>, a normal aerobic member of the skin flora, was present in 58% of the samples, making it one of the most common pathogens observed<sup><a href="#ref-84">84</a></sup>. The pathogens most commonly implicated in HS inflammatory lesions are benign on unaffected skin. This indicates a structural or immunologic abnormality that allows for bacterial overgrowth in HS patients, although future studies are needed to validate this hypothesis. There is still much to be learned about the microbiome and its role in HS.</p><p class="" id=d28013e878>Of particular interest is the complication of bacterial biofilms in HS lesions. Biofilms are observed in a variety of diseases and are associated with classic findings of chronic, non-healing inflammatory lesions with episodic acute-on-chronic flares. Often responsive at first, then resistant to antibiotic treatments, biofilm-associated lesions cause a great deal of difficulty in management. Bacterial metabolic adaptations often lower the efficacy of antimicrobial agents, making the lesions more difficult to treat<sup><a href="#ref-85">85</a></sup>. Biofilm development also results in a physical barrier, further contributing to decreased antibiotic efficacy. The three strains of bacteria most commonly implicated in biofilm disorders are <i>Pseudomonas aeruginosa, Enterococcus faecalis,</i> and <i>S. aureus</i><sup><a href="#ref-86">86</a></sup>.</p><p class="" id=d28013e894>A recent study evaluated perilesional biopsies of 42 patients with chronic HS and found that 67% of the samples showed evidence of biofilms. Larger biofilms were associated with more extensive disease<sup><a href="#ref-85">85</a></sup>. Interestingly, another study evaluated acute HS lesions in 10 patients and found no evidence of biofilms<sup><a href="#ref-87">87</a></sup>. Although the sample size was small, this finding supports the current understanding that biofilms develop in chronic lesions. The discovery of biofilms in HS has improved the understanding of the disease process and will lead to many new directions in treatment options targeting this aspect of pathology<sup><a href="#ref-85">85</a>,<a href="#ref-88">88</a></sup>. Methods of managing chronic wounds associated with biofilms are discussed below.</p></div><div class=section><a name=d28013e913 class=n-a></a><h3 class=section-title>Classification systems</h3><p class="" id=d28013e918>A variety of classification systems have been proposed to assess disease severity, although, recently, many methods have been developed in an attempt to capture treatment efficacy.</p><p class="" id=d28013e921>Hurley staging was one of the first techniques to categorize HS severity based on lesion type and proximity of neighboring lesions<sup><a href="#ref-1">1</a>,<a href="#ref-89">89</a></sup>. Of clinical utility, a positive correlation of CRP levels was associated with more advanced Hurley staging<sup><a href="#ref-90">90</a></sup>. The Sartorius system incorporates lesion quantity and location, distance between lesions, and presence of unaffected skin in clinical staging<sup><a href="#ref-5">5</a></sup>. The Physician Global Assessment (PGA) scale details six stages of disease process based on clinical criteria, with stage-specific guidelines for management and follow-up<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d28013e943>More recently, the HS Clinical Response (HiSCR) was formulated to evaluate HS stability and assess clinical improvement. The HiSCR system first determines the patient’s baseline number of abscesses and inflammatory nodules (AN count). HiSCR is a clinically determined endpoint of the disease; achievement of HiSCR50 occurs when a 50% reduction in total AN count is observed, with no increase in abscesses or draining fistulas compared to baseline<sup><a href="#ref-91">91</a></sup>. The ability to assess the transient inflammatory components of HS is a strength of this assessment technique. Overall, although clinical staging has been helpful in the management of HS, scoring techniques often underestimate disease severity compared to other modalities, such as ultrasound<sup><a href="#ref-92">92</a></sup>.</p><p class="" id=d28013e954>The underestimation of severity through clinical diagnosis may lead to less desirable outcomes in management. Wortsman <i>et al</i>. reported a surprising 82% modification in management approach, from medical to surgical, owing to anatomic details observed on ultrasound that were missed on physical examination<sup><a href="#ref-92">92</a></sup>. The Sonographic Scoring of HS (SOS-HS) technique, developed by Wortsman <i>et al</i>., is a standardized method of HS severity assessment using ultrasound techniques to examine HS lesions<sup><a href="#ref-92">92</a>–<a href="#ref-94">94</a></sup>. The use of ultrasonography in HS staging may be a valuable tool to stage HS and guide management.</p><p class="" id=d28013e975>Overall, a consensus of diagnostic criteria and treatment recommendations is needed to improve and streamline HS management<sup><a href="#ref-4">4</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e986>Management of hidradenitis suppurativa</h2><p class="" id=d28013e989>Treatment for HS is guided by disease severity and symptomatology. While the medical, surgical, and laser management sections are separated for ease of discussion, these treatment options are not exclusive but rather exist on a continuum and are often combined to optimize treatment response. Additionally, it is important to address and properly treat underlying medical conditions to comprehensively manage patients. To date, there is no widely accepted, evidence-based treatment algorithm, although evidence-based treatment ladders have been suggested. The Henry Ford Health System in Detroit, MI, proposed an algorithm of HS management based on the treatment of more than 1,000 patients in a dedicated follicular disorders clinic (see <a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12238/a0fca29a-fb3f-435e-9f2c-ea1dec998482_figure1.gif"><img alt="a0fca29a-fb3f-435e-9f2c-ea1dec998482_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12238/a0fca29a-fb3f-435e-9f2c-ea1dec998482_figure1.gif"></a><div class=caption><h3>Figure 1. Henry Ford Hospital hidradenitis suppurativa (HS) treatment algorithm.</h3><p id=d28013e1005>This treatment algorithm is used in the Henry Ford Dermatology Clinic, which provides care to more than 1,000 patients with HS. The algorithm is based on a combination of evidence-based research and provider experience. BID, <i>bis in die</i>; I/L, intralesional; IV, intravenously; Nd:YAG, neodymium-doped yttrium aluminum garnet; QD, <i>quaque die</i>.</p></div></div><div class=section><a name=d28013e1018 class=n-a></a><h3 class=section-title>Medical management</h3><p class="" id=d28013e1023>Medical treatment optimizes a combination of agents including keratolytics, such as benzoyl peroxide or resorcinol, topical antibiotics, systemic antibiotics, hormonal modulators, systemic retinoids, intralesional corticosteroids, and, more recently, biologics and immunomodulators. The goal of medical management is to decrease disease burden and symptoms with the intent of reaching a state of remission.</p><p class="" id=d28013e1026>Gulliver <i>et al</i>. used the European Dermatology Forum guidelines to create a treatment algorithm. This article recommended that a dermatologist well versed in HS should act as the primary coordinator of care and, initially, lifestyle modifications should always be offered. Treatment for HS begins with topical or oral antibiotics, such as clindamycin and oral tetracycline, respectively, followed by the use of rifampicin if there is no improvement. Next, biologic therapy is offered, which should be continued if the patient responds. If the response is inadequate or the patient cannot take biologics, transition to second- or third-line options is reasonable, including surgical or laser approaches when options have been exhausted, as discussed below. The treatment regimen of advanced HS is currently in a fluid state, although research and evidence-based medicine is guiding the way towards a consensus<sup><a href="#ref-95">95</a></sup>.</p><p class="" id=d28013e1036>Antibiotic treatments for HS begin as broad-spectrum regimens. Bettoli <i>et al</i>. suggested that, to improve outcomes, a multidisciplinary team approach as well as antimicrobial stewardship should be implemented to prevent long-term sequelae such as resistance, relapses, and over- or under-treatment of disease<sup><a href="#ref-96">96</a></sup>. Despite our best efforts, unfortunately antimicrobial resistance in HS has been reported<sup><a href="#ref-97">97</a></sup>.</p><p class="" id=d28013e1050>When topical medications and oral antibiotics fail, or the disease has progressed, biologic medications can be recommended. Adalimumab, a TNF-α inhibitor, has the most evidence supporting its use. Two open-label, phase II, randomized controlled trials (RCTs) determined that weekly dosing of adalimumab statistically improved clinical response when compared to placebo controls<sup><a href="#ref-98">98</a>,<a href="#ref-99">99</a></sup>. Following these studies, two phase III trials, PIONEER I and II, described statistically improved clinical response in the adalimumab treatment group compared to placebo after 12 weeks. Specifically, 41.8% of the treated group reached HiSCR compared to 26.0% of the placebo group in PIONEER I (<i>p</i> = 0.003) and 58.9% versus 27.6% in PIONEER II (<i>p</i>&lt;0.001), respectively. PIONEER II also noted a statistically significant improvement in Sartorius score, from a mean of 81.4 before treatment to 52.5 at week 12 (<i>p</i>&lt;0.001)<sup><a href="#ref-75">75</a></sup>.</p><p class="" id=d28013e1074>Second-line treatments are reasonable options in non-responders. These include infliximab (another TNF-α inhibitor) and anti-androgen therapy. Other methods of management, although fewer data exist to support their efficacy, include metformin, IL-1 receptor antagonists such as anakinra, anti-IL-17 agents, and IL-12/IL-23 pathway inhibitors such as ustekinumab.</p><p class="" id=d28013e1077>Infliximab and etanercept have been used in the management of HS. Infliximab was one of the first TNF-α inhibitors evaluated for HS. Previous studies indicated success with infliximab treatments<sup><a href="#ref-100">100</a>,<a href="#ref-101">101</a></sup>. In an eight-week, phase II study of 20 patients with moderate-to-severe HS treated with infliximab, significant improvement in pain, clinical disease severity, and quality of life were reported compared to controls<sup><a href="#ref-102">102</a></sup>. Subsequently, Moriarty <i>et al</i>. optimized dosing regimens to every four weeks<sup><a href="#ref-99">99</a></sup>. Although support for the use of infliximab is strong, adalimumab offers ease of administration compared to infliximab<sup><a href="#ref-103">103</a></sup>. However, in the authors’ experience, infliximab is more efficacious in refractory patients, despite not having FDA approval for this indication.</p><p class="" id=d28013e1102>Etanercept is another TNF-α inhibitor of interest in the management of HS. Although initial studies were promising, subsequent studies failed to demonstrate efficacy<sup><a href="#ref-104">104</a>,<a href="#ref-105">105</a></sup>.</p><p class="" id=d28013e1112>Because of the involvement of the IL-12/Th1 and IL-23/Th17 pathways in the pathogenesis of HS, ustekinumab, a human monoclonal antibody that targets IL-12 and IL-23, was proposed as a potential modulator of HS. The first open-label study used 45 or 90 mg of ustekinumab at 0, 4, 16, and 28 weeks, which resulted in improved Sartorius scoring in 82% of 17 total patients<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d28013e1119>Anakinra is an IL-1 receptor antagonist that has been implicated in the treatment of HS because of the noted elevated levels of this inflammatory cytokine and is also used in the management of AIDs owing to the role of IL-1 as a pro-inflammatory agent in this spectrum of diseases as well<sup><a href="#ref-106">106</a></sup>. Two studies have reported the efficacy of anakinra for HS; the first was an open-label study, in which five patients given 100 mg of subcutaneous anakinra showed improvement based on the modified Sartorius scoring system after 8 weeks<sup><a href="#ref-107">107</a></sup>. The second study supported these findings in Hurley stage II and III patients treated with anakinra for 12 weeks. It was found that disease activity and IFN-γ levels significantly decreased compared to in controls<sup><a href="#ref-71">71</a>,<a href="#ref-107">107</a></sup>. These studies provided evidence to support continued assessments of anakinra as a plausible future treatment option.</p><p class="" id=d28013e1137>Another promising treatment for HS is ertapenem. In a pilot study evaluating the use of ertapenem in patients with severe HS, a six-week course of 1 g of intravenous (IV) ertapenem daily followed by a consolidation treatment resulted in improved Sartorius scores. Further improvement was noted during the consolidation treatments. Patients who were not able to or did not complete the treatment stopped improving and some returned to their baseline severe disease<sup><a href="#ref-108">108</a></sup>.</p><p class="" id=d28013e1145>Of interest in the management of HS is the use of metformin. In a small clinical study, 25 patients with refractory HS were initiated on metformin for a period of 24 weeks. Following the course, there was a significant improvement in Sartorius scores. This study seemed to strengthen the association among metabolic syndrome, disease severity, and perhaps hormonal imbalances in HS, as metformin also has anti-androgen properties<sup><a href="#ref-109">109</a></sup>. Although these initial findings were promising, subsequent studies are needed<sup><a href="#ref-110">110</a></sup>. It is important to always recommend lifestyle modifications in treatment plans, as metabolic syndrome increases the risk for many other medical complications.</p><p class="" id=d28013e1156>Colchicine, an anti-inflammatory medication, was previously discredited in having a role in HS management<sup><a href="#ref-111">111</a></sup>. However, a 2017 study by Armyra <i>et al</i>. indicated that colchicine might provide some clinical benefit in combination with tetracycline. This prospective series study treated all 20 patients with 100 mg minocycline daily in combination with 0.5 mg colchicine daily for 3 months. Using Hurley and Dermatology Life Quality Index (DLQI) scoring techniques, significant improvement in HS symptoms was observed<sup><a href="#ref-112">112</a></sup>.</p><p class="" id=d28013e1170>Anti-androgen therapy has also been used in the treatment of HS. A small case series involving 20 women with mild- to moderate-severity HS were treated with spironolactone, an androgen receptor blocker, which showed improvements in disease activity. However, some of the patients were concurrently taking oral contraception, and five were taking minocycline<sup><a href="#ref-113">113</a></sup>. The side effects of the medication were reported to be minimal, providing evidence to support further studies on the efficacy of spironolactone. Again, comorbid disease states may be a confounding factor, and lifestyle modifications for overall health are key to appropriately managing HS patients.</p><p class="" id=d28013e1177>Biofilms pose a difficult challenge in HS management. For successful treatment, it is necessary to break down the biofilm. There is evidence to support the use of biofilm-penetrating gels, which consist of a pH buffer, benzalkonium chloride surfactant, as well as antimicrobial activity, in other chronic non-HS-related wounds<sup><a href="#ref-114">114</a></sup>. Although this study was not specific to HS, it is implied that similar mechanisms may benefit chronic HS lesions. Inhibition of biofilm formation is another mechanism that may benefit HS patients. In the Lubbock chronic wound biofilm (LCWB) model, xylitol, salicylic acid, erythritol, and two novel Sanguitec gels, combined in semi-solid wound dressing formulations, inhibited biofilm formation from <i>P. aeruginosa</i>, <i>E. faecalis</i>, and <i>S. aureus</i> in the laboratory setting<sup><a href="#ref-86">86</a></sup>. Future directions in HS research must include HS disease-specific biofilm management techniques to improve wound care.</p><p class="" id=d28013e1197>The treatment of disease through intralesional corticosteroids is a unique method of symptomatic management, but, previously, evidence was limited. Intralesional triamcinolone in 10 patients resulted in both physician- and patient-reported improvement. Significant reductions in physician-assessed levels of erythema, edema, suppuration, and size were noted on days 1 and 2 following injections, while patient-reported pain scores were also significantly improved. This study provided evidence to support intralesional corticosteroid injections, although it was limited by the small sample size and lack of control group<sup><a href="#ref-115">115</a></sup>. Additionally, the natural history of HS lesions with progression towards reduced inflammation, pain, and drainage complicates the interpretation of these results.</p><p class="" id=d28013e1204>Lifestyle modifications are a major form of management that should be addressed and recommended to all patients. In particular, it is known that cigarette smoking impedes healing. In a retrospective cohort study, non-smokers were significantly more likely to exhibit improvements following first-line treatments compared to smoking counterparts<sup><a href="#ref-116">116</a></sup>. In addition to smoking cessation, weight loss of more than 15% is associated with a significant improvement in disease severity<sup><a href="#ref-8">8</a>,<a href="#ref-117">117</a></sup>. It is beneficial to consider lifestyle modifications in the management of all patients with HS, along with routine treatments.</p></div><div class=section><a name=d28013e1219 class=n-a></a><h3 class=section-title>Surgical and laser management</h3><p class="" id=d28013e1224>When medical management is ineffective, surgery is often the next step for HS treatment. Surgical management generally involves excision of the lesional material with or without the removal of associated scar tissue. There are both localized and extensive surgical interventions. Although there is no consensus on the best approach, procedures are carried out based on disease severity and location, with the overall goal of removing lesional tissue and sparing healthy skin to optimize outcomes.</p><p class="" id=d28013e1227>Many approaches exist to manage HS, including local destruction, incision and drainage (I&amp;D), standard unroofing, and wide excision techniques<sup><a href="#ref-118">118</a></sup>. Local destruction is used to ablate HS lesions and may be carried out with electrosurgery, cryotherapy, or laser removal. I&amp;D may be used for decompression in acute episodes of unbearable pain. However, I&amp;D does not assist in the long-term resolution of disease, as the inflamed tissue remains and infection is almost certain to recur<sup><a href="#ref-119">119</a></sup>. Unroofing techniques are effective for both small and large lesional units and are carried out by opening the surface of all connected abscesses and tracts within an HS lesion. The contents are removed by curettage, often leaving the site open to heal by secondary intention<sup><a href="#ref-120">120</a></sup>. Unroofing techniques are preferred for Hurley stage I/II, whereas skin-tissue-saving excision with electrosurgical peeling (STEEP) is preferred for Hurley stage II/III. STEEP similarly removes diseased, fibrotic tissue via electrosurgical loop while sparing healthy skin to decrease sequelae following the surgical procedure<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup>. Lesions that cannot be unroofed may be excised, which includes the removal of the entire diseased area up to the margins of normal-appearing subcutaneous tissue<sup><a href="#ref-118">118</a></sup>.</p><p class="" id=d28013e1253>The best surgical approach for long-term outcomes is controversial and is dependent on the patient’s disease severity and location of the lesions. A recent systematic review and meta-analysis assessed for recurrence rates with varying methods of surgical management. The lowest rates of recurrence occurred following wide excision therapy when compared to local excision and deroofing procedures. This study also indicated that recurrence rates were lowest with skin grafts and skin flaps compared to primary closure, although this was limited by retrospective analysis and lack of randomization of closures<sup><a href="#ref-123">123</a></sup>. Wide excision followed by secondary intention healing was also shown to be functional and aesthetically acceptable to patients<sup><a href="#ref-124">124</a></sup>. Bias may exist in the discrepancy between recurrence rates and type of closure owing to the fact that primary closure is possible only with smaller wound sizes compared to larger excisions that simply cannot be closed by primary intention. Although this has not been formally assessed, the size of the wound may play a role.</p><p class="" id=d28013e1264>The use of lasers in HS management has gained recent popularity. The 1064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser appears to be an effective, novel modality in HS management. After a series of treatments, two trials reported decreases in HS-associated inflammation, scarring, and fibrosis, indicating successful, selective photothermolysis to manage the disease<sup><a href="#ref-125">125</a>,<a href="#ref-126">126</a></sup>. It is best used in recalcitrant Hurley stage I and II patients.</p><p class="" id=d28013e1275>Another type of laser used in the treatment of HS is the carbon dioxide (CO<sub>2</sub>) laser, which is used to excise HS lesions and ablate pathologic tissues. CO<sub>2</sub> laser has been used since the late 1980s for HS, although it is now increasing in popularity. Laser excision followed by marsupialization has been shown to be effective for the management of persistent or late-stage cases of HS, with overall patient satisfaction in post-operative quality of life and pain measures<sup><a href="#ref-127">127</a>,<a href="#ref-128">128</a></sup>. Additionally, a retrospective study (n = 58) of CO<sub>2</sub> laser evaporation techniques reported a 29% recurrence rate of disease within 12.2 months of the procedure (noted around the borders of treated regions), while 95% of patients reported some or great improvement in disease status<sup><a href="#ref-129">129</a></sup>. A reported complication of CO<sub>2</sub> excision is scar contracture, restricted range of motion, and delayed wound healing. Nicholson <i>et al</i>. determined that fractional CO<sub>2</sub> therapy could be a helpful adjunct in these cases<sup><a href="#ref-130">130</a></sup>. For further reading, see <a href="#ref-131">131</a>–<a href="#ref-134">134</a>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e1323>Psychosocial impact</h2><p class="" id=d28013e1326>HS can be a debilitating disease, physically and emotionally, with increased prevalence of depression and psychiatric disease noted in this patient population. Onderdijk <i>et al</i>. evaluated patient-reported levels of depression, as determined through the Major Depression Inventory (MDI) questionnaire, which indicated higher scores for patients with HS compared to controls. However, clinically defined depression was not statistically more frequent. DLQI scores were significantly higher in patients with HS, indicating greater daily impact of disease<sup><a href="#ref-37">37</a></sup>. A more recent cross-sectional study utilized a database of over 4 million patients, 3,207 with HS, and found a significant association between depression and anxiety<sup><a href="#ref-36">36</a></sup>. Most recently, Kouris <i>et al</i>. noted a significant association between HS and depression, anxiety, and social isolation, as well as lower levels of self-esteem, compared to controls<sup><a href="#ref-135">135</a></sup>. These studies reinforced the need for psychiatric evaluations as part of routine care for HS patients.</p><p class="" id=d28013e1347>Due to the sensitive location of HS lesions, sexual health is often a concern for patients and their partners. A survey-based multicenter cross-sectional study of 916 HS patients reported decreased quality of life and overall sexual health as assessed by scoring techniques such as Female Sexual Function Index, International Index of Erectile Function, and DLQI<sup><a href="#ref-2">2</a></sup>. This was one of the first large-scale assessments published on the matter. In the authors’ experience, coordination with psychiatrists, psychologists, and sexual health therapists experienced in the impacts of chronic disease and chronic pain can be a valuable resource in the multidisciplinary approach to manage HS.</p><p class="" id=d28013e1354>Social isolation and loneliness are detrimental to overall health. In a review of over 3,000 individuals, Holt-Lundstat <i>et al</i>. found an increased risk of mortality in subjects who reported feelings of loneliness and social isolation. Mortality risk was comparable to well-established risk factors, such as obesity. Subjects reporting loneliness saw a 26% increased risk of mortality, while those reporting social isolation saw a 29% increased risk of mortality<sup><a href="#ref-136">136</a></sup>. To combat the impacts of social isolation and loneliness, support groups can be a useful resource for both patients and providers.</p><p class="" id=d28013e1364>There are a variety of support groups dedicated to HS, the majority of which are social media based, and a few in-person support groups. Regardless of the format, support groups offer patients the ability to interact with others facing similar circumstances and provide a sense of validation that only others with HS can provide. As with other chronic diseases, the impacts of HS are felt by caregivers, spouses, partners, family members, and friends. Participation in support groups should be considered not only for the patient but also for the caregiver.</p><p class="" id=d28013e1368>In the author’s experience, a support group that involves medical providers hosts a successful and productive format. Those with HS have often had unpleasant experiences in medicine, having suffered through mismanagement of their care and a delay in diagnosis<sup><a href="#ref-10">10</a></sup>. Provider involvement can ensure that accurate information about HS is disseminated and discussed. Patients can provide feedback on treatments and also make their own suggestions for new treatment options. Additionally, a provider- and patient-driven format provides an avenue to rebuild trust and the opportunity to gain insight into disease impacts through an informal setting without clinical time constraints.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28013e1378>Future directions</h2><p class="" id=d28013e1381>Great strides in the understanding of HS have been achieved in recent years. However, additional studies are needed to improve treatment options and patient outcomes moving forward. Future directions include increasing the awareness of HS in all fields of medicine to improve diagnoses and management, as well as continued treatment exploration, using updated knowledge on the pathogenesis of disease as the framework for future studies. With these collaborative goals in mind, multidisciplinary teams will continue to strive for success in overcoming this distressing disease.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d28013e1 class=n-a></a><h2 class=main-title id=d28450>Author contributions</h2><p class=metadata-entry><a name=d28013e127 class=n-a></a><p id=d28013e129> Mallory Smith and Cynthia Nicholson drafted and wrote the article. Angela Miller contributed expertise for the “Psychosocial impact” section, and Iltefat Hamzavi contributed expertise on disease management. All authors were involved in the manuscript revisions and agreed on the final submission.</p></p></div><div class=back-section><a name=d28013e1 class=n-a></a><h2 class=main-title id=d28454>Competing interests</h2><p class=metadata-entry><a name=d28013e133 class=n-a></a><p id=d28013e135> Iltefat Hamzavi is the current president of the Hidradenitis Suppurativa Foundation (non-funded) and was an investigator for AbbVie. Angela Miller has served on an advisory board and as a consultant for AbbVie and is an employee of the Hidradenitis Suppurativa Foundation. Cynthia Nicholson and Mallory Smith declare that they do not have any competing interests.</p></p></div><div class=back-section><a name=d28013e1 class=n-a></a><h2 class=main-title id=d28456>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d28013e1388 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d28876>References</h2><div class="section ref-list"><a name=d28013e1388 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d28013e1395 class=n-a></a>Gill L, Williams M, Hamzavi I: Update on hidradenitis suppurativa: connecting the tracts. <i>F1000Prime Rep.</i> 2014; <b>6</b>: 112. <a target=xrefwindow id=d28013e1403 href="http://www.ncbi.nlm.nih.gov/pubmed/25580266">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1406 href="http://dx.doi.org/10.12703/P6-112">Publisher Full Text </a> | <a target=xrefwindow id=d28013e1409 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4278191">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d28013e1418 class=n-a></a>Janse IC, Deckers IE, van der Maten AD, <i> et al.</i>: Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. <i>Br J Dermatol.</i> 2017; <b>176</b>(4): 1042–7. <a target=xrefwindow id=d28013e1429 href="http://www.ncbi.nlm.nih.gov/pubmed/27534591">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1432 href="http://dx.doi.org/10.1111/bjd.14975">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d28013e1441 class=n-a></a>Alavi A, Anooshirvani N, Kim WB, <i> et al.</i>: Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. <i>Am J Clin Dermatol.</i> 2015; <b>16</b>(1): 61–5. <a target=xrefwindow id=d28013e1452 href="http://www.ncbi.nlm.nih.gov/pubmed/25432664">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1455 href="http://dx.doi.org/10.1007/s40257-014-0105-5">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d28013e1464 class=n-a></a>Zouboulis CC, Del Marmol V, Mrowietz U, <i> et al.</i>: Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation. <i>Dermatology.</i> 2015; <b>231</b>(2): 184–90. <a target=xrefwindow id=d28013e1475 href="http://www.ncbi.nlm.nih.gov/pubmed/26139027">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1478 href="http://dx.doi.org/10.1159/000431175">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/721061425"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e1487 class=n-a></a>Alikhan A, Lynch PJ, Eisen DB: Hidradenitis suppurativa: a comprehensive review. <i>J Am Acad Dermatol.</i> 2009; <b>60</b>(4): 539–61; quiz 562–3. <a target=xrefwindow id=d28013e1495 href="http://www.ncbi.nlm.nih.gov/pubmed/19293006">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1498 href="http://dx.doi.org/10.1016/j.jaad.2008.11.911">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/721061425">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d28013e1512 class=n-a></a>Miller IM, McAndrew RJ, Hamzavi I: Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. <i>Dermatol Clin.</i> 2016; <b>34</b>(1): 7–16. <a target=xrefwindow id=d28013e1520 href="http://www.ncbi.nlm.nih.gov/pubmed/26617352">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1523 href="http://dx.doi.org/10.1016/j.det.2015.08.002">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d28013e1532 class=n-a></a>Revuz J: Hidradenitis suppurativa. <i>J Eur Acad Dermatol Venereol.</i> 2009; <b>23</b>(9): 985–98. <a target=xrefwindow id=d28013e1540 href="http://www.ncbi.nlm.nih.gov/pubmed/19682181">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1543 href="http://dx.doi.org/10.1111/j.1468-3083.2009.03356.x">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d28013e1552 class=n-a></a>Kromann CB, Ibler KS, Kristiansen VB, <i> et al.</i>: The influence of body weight on the prevalence and severity of hidradenitis suppurativa. <i>Acta Derm Venereol.</i> 2014; <b>94</b>(5): 553–7. <a target=xrefwindow id=d28013e1563 href="http://www.ncbi.nlm.nih.gov/pubmed/24577555">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1566 href="http://dx.doi.org/10.2340/00015555-1800">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d28013e1575 class=n-a></a>Reeder VJ, Mahan MG, Hamzavi IH: Ethnicity and hidradenitis suppurativa. <i>J Invest Dermatol.</i> 2014; <b>134</b>(11): 2842–3. <a target=xrefwindow id=d28013e1583 href="http://www.ncbi.nlm.nih.gov/pubmed/24820891">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1586 href="http://dx.doi.org/10.1038/jid.2014.220">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d28013e1595 class=n-a></a>Saunte DM, Boer J, Stratigos A, <i> et al.</i>: Diagnostic delay in hidradenitis suppurativa is a global problem. <i>Br J Dermatol.</i> 2015; <b>173</b>(6): 1546–9. <a target=xrefwindow id=d28013e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/26198191">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1609 href="http://dx.doi.org/10.1111/bjd.14038">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d28013e1618 class=n-a></a>Jemec GB, Heidenheim M, Nielsen NH: The prevalence of hidradenitis suppurativa and its potential precursor lesions. <i>J Am Acad Dermatol.</i> 1996; <b>35</b>(2 Pt 1): 191–4. <a target=xrefwindow id=d28013e1626 href="http://www.ncbi.nlm.nih.gov/pubmed/8708018">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1629 href="http://dx.doi.org/10.1016/S0190-9622(96)90321-7">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d28013e1639 class=n-a></a>Revuz JE, Canoui-Poitrine F, Wolkenstein P, <i> et al.</i>: Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. <i>J Am Acad Dermatol.</i> 2008; <b>59</b>(4): 596–601. <a target=xrefwindow id=d28013e1650 href="http://www.ncbi.nlm.nih.gov/pubmed/18674845">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1653 href="http://dx.doi.org/10.1016/j.jaad.2008.06.020">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d28013e1662 class=n-a></a>Cosmatos I, Matcho A, Weinstein R, <i> et al.</i>: Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. <i>J Am Acad Dermatol.</i> 2013; <b>68</b>(3): 412–9. <a target=xrefwindow id=d28013e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/22921795">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1676 href="http://dx.doi.org/10.1016/j.jaad.2012.07.027">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d28013e1685 class=n-a></a>Shahi V, Alikhan A, Vazquez BG, <i> et al.</i>: Prevalence of hidradenitis suppurativa: a population-based study in Olmsted County, Minnesota. <i>Dermatology.</i> 2014; <b>229</b>(2): 154–8. <a target=xrefwindow id=d28013e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/25228133">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1699 href="http://dx.doi.org/10.1159/000363381">Publisher Full Text </a> | <a target=xrefwindow id=d28013e1703 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4216603">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d28013e1712 class=n-a></a>Vinding GR, Miller IM, Zarchi K, <i> et al.</i>: The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. <i>Br J Dermatol.</i> 2014; <b>170</b>(4): 884–9. <a target=xrefwindow id=d28013e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/24329520">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1726 href="http://dx.doi.org/10.1111/bjd.12787">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d28013e1735 class=n-a></a>Dufour DN, Bryld LE, Jemec GB: Hidradenitis suppurativa complicating naevus comedonicus: the possible influence of mechanical stress on the development of hidradenitis suppurativa. <i>Dermatology.</i> 2010; <b>220</b>(4): 323–5. <a target=xrefwindow id=d28013e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/20389029">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1746 href="http://dx.doi.org/10.1159/000287261">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d28013e1755 class=n-a></a>Danby FW: Diet in the prevention of hidradenitis suppurativa (acne inversa). <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(5 Suppl 1): S52–4. <a target=xrefwindow id=d28013e1763 href="http://www.ncbi.nlm.nih.gov/pubmed/26470617">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1766 href="http://dx.doi.org/10.1016/j.jaad.2015.07.042">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d28013e1776 class=n-a></a>Cannistrà C, Finocchi V, Trivisonno A, <i> et al.</i>: New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer's yeast-exclusion diet. <i>Surgery.</i> 2013; <b>154</b>(5): 1126–30. <a target=xrefwindow id=d28013e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/23891479">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1790 href="http://dx.doi.org/10.1016/j.surg.2013.04.018">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d28013e1799 class=n-a></a>König A, Lehmann C, Rompel R, <i> et al.</i>: Cigarette smoking as a triggering factor of hidradenitis suppurativa. <i>Dermatology.</i> 1999; <b>198</b>(3): 261–4. <a target=xrefwindow id=d28013e1810 href="http://www.ncbi.nlm.nih.gov/pubmed/10393449">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1813 href="http://dx.doi.org/10.1159/000018126">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726010578"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e1822 class=n-a></a>Miller IM, Rytgaard H, Mogensen UB, <i> et al.</i>: Body composition and basal metabolic rate in Hidradenitis Suppurativa: a Danish population-based and hospital-based cross-sectional study. <i>J Eur Acad Dermatol Venereol.</i> 2016; <b>30</b>(6): 980–8. <a target=xrefwindow id=d28013e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/26660945">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1836 href="http://dx.doi.org/10.1111/jdv.13522">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726010578">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d28013e1849 class=n-a></a>Shlyankevich J, Chen AJ, Kim GE, <i> et al.</i>: Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. <i>J Am Acad Dermatol.</i> 2014; <b>71</b>(6): 1144–50. <a target=xrefwindow id=d28013e1860 href="http://www.ncbi.nlm.nih.gov/pubmed/25440440">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1863 href="http://dx.doi.org/10.1016/j.jaad.2014.09.012">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718242000"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e1872 class=n-a></a>Gold DA, Reeder VJ, Mahan MG, <i> et al.</i>: The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2014; <b>70</b>(4): 699–703. <a target=xrefwindow id=d28013e1883 href="http://www.ncbi.nlm.nih.gov/pubmed/24433875">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1886 href="http://dx.doi.org/10.1016/j.jaad.2013.11.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718242000">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d28013e1899 class=n-a></a>Miller IM, Ellervik C, Vinding GR, <i> et al.</i>: Association of metabolic syndrome and hidradenitis suppurativa. <i>JAMA Dermatol.</i> 2014; <b>150</b>(12): 1273–80. <a target=xrefwindow id=d28013e1910 href="http://www.ncbi.nlm.nih.gov/pubmed/25229996">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1913 href="http://dx.doi.org/10.1001/jamadermatol.2014.1165">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726416374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e1923 class=n-a></a>González-López MA, Hernández JL, Lacalle M, <i> et al.</i>: Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). <i>J Am Acad Dermatol.</i> 2016; <b>75</b>(2): 329–35. <a target=xrefwindow id=d28013e1934 href="http://www.ncbi.nlm.nih.gov/pubmed/27287248">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1937 href="http://dx.doi.org/10.1016/j.jaad.2016.03.025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726416374">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d28013e1950 class=n-a></a>Matusiak Ł, Szczęch J, Bieniek A, <i> et al.</i>: Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(4): 670–5. <a target=xrefwindow id=d28013e1961 href="http://www.ncbi.nlm.nih.gov/pubmed/28041632">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1964 href="http://dx.doi.org/10.1016/j.jaad.2016.10.042">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726151869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e1973 class=n-a></a>Egeberg A, Gislason GH, Hansen PR: Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa. <i>JAMA Dermatol.</i> 2016; <b>152</b>(4): 429–34. <a target=xrefwindow id=d28013e1981 href="http://www.ncbi.nlm.nih.gov/pubmed/26885728">PubMed Abstract </a> | <a target=xrefwindow id=d28013e1984 href="http://dx.doi.org/10.1001/jamadermatol.2015.6264">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726151869">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d28013e1997 class=n-a></a>Kohorst JJ, Kimball AB, Davis MD: Systemic associations of hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(5 Suppl 1):S27–35. <a target=xrefwindow id=d28013e2005 href="http://www.ncbi.nlm.nih.gov/pubmed/26470611">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2008 href="http://dx.doi.org/10.1016/j.jaad.2015.07.055">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d28013e2017 class=n-a></a>van der Zee HH, van der Woude CJ, Florencia EF, <i> et al.</i>: Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. <i>Br J Dermatol.</i> 2010; <b>162</b>(1): 195–7. <a target=xrefwindow id=d28013e2028 href="http://www.ncbi.nlm.nih.gov/pubmed/19681876">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2031 href="http://dx.doi.org/10.1111/j.1365-2133.2009.09430.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727212442"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2040 class=n-a></a>Egeberg A, Jemec GBE, Kimball AB, <i> et al.</i>: Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa. <i>J Invest Dermatol.</i> 2017; <b>137</b>(5): 1060–4. <a target=xrefwindow id=d28013e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/28089682">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2054 href="http://dx.doi.org/10.1016/j.jid.2016.11.040">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727212442">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726900080"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2068 class=n-a></a>Deckers IE, Benhadou F, Koldijk MJ, <i> et al.</i>: Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(1): 49–53. <a target=xrefwindow id=d28013e2079 href="http://www.ncbi.nlm.nih.gov/pubmed/27793450">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2082 href="http://dx.doi.org/10.1016/j.jaad.2016.08.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726900080">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725480215"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2095 class=n-a></a>Yadav S, Singh S, Edakkanambeth Varayil J, <i> et al.</i>: Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. <i>Clin Gastroenterol Hepatol.</i> 2016; <b>14</b>(1): 65–70. <a target=xrefwindow id=d28013e2106 href="http://www.ncbi.nlm.nih.gov/pubmed/25952308">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2109 href="http://dx.doi.org/10.1016/j.cgh.2015.04.173">Publisher Full Text </a> | <a target=xrefwindow id=d28013e2113 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4635068">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725480215">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725232920"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2126 class=n-a></a>Fimmel S, Zouboulis CC: Comorbidities of hidradenitis suppurativa (acne inversa). <i>Dermatoendocrinol.</i> 2010; <b>2</b>(1): 9–16. <a target=xrefwindow id=d28013e2134 href="http://www.ncbi.nlm.nih.gov/pubmed/21547142">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2137 href="http://dx.doi.org/10.4161/derm.2.1.12490">Publisher Full Text </a> | <a target=xrefwindow id=d28013e2140 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3084959">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725232920">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d28013e2153 class=n-a></a>Herschel S, Laske J, Stein A: Squamous cell carcinoma arising in hidradenitis suppurativa. <i>J Dtsch Dermatol Ges.</i> 2014; <b>12</b>(5): 417–9. <a target=xrefwindow id=d28013e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/24628697">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2164 href="http://dx.doi.org/10.1111/ddg.12279">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d28013e2173 class=n-a></a>Pena ZG, Sivamani RK, Konia TH, <i> et al.</i>: Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature. <i>Dermatol Online J.</i> 2015; <b>21</b>(4): pii: 13030/qt9q9707dp. <a target=xrefwindow id=d28013e2184 href="http://www.ncbi.nlm.nih.gov/pubmed/25933081">PubMed Abstract </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d28013e2193 class=n-a></a>Lavogiez C, Delaporte E, Darras-Vercambre S, <i> et al.</i>: Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. <i>Dermatology.</i> 2010; <b>220</b>(2): 147–53. <a target=xrefwindow id=d28013e2204 href="http://www.ncbi.nlm.nih.gov/pubmed/20029163">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2207 href="http://dx.doi.org/10.1159/000269836">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d28013e2217 class=n-a></a>Shavit E, Dreiher J, Freud T, <i> et al.</i>: Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. <i>J Eur Acad Dermatol Venereol.</i> 2015; <b>29</b>(2): 371–6. <a target=xrefwindow id=d28013e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/24909646">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2231 href="http://dx.doi.org/10.1111/jdv.12567">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d28013e2240 class=n-a></a>Onderdijk AJ, van der Zee HH, Esmann S, <i> et al.</i>: Depression in patients with hidradenitis suppurativa. <i>J Eur Acad Dermatol Venereol.</i> 2013; <b>27</b>(4): 473–8. <a target=xrefwindow id=d28013e2251 href="http://www.ncbi.nlm.nih.gov/pubmed/22339940">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2254 href="http://dx.doi.org/10.1111/j.1468-3083.2012.04468.x">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d28013e2263 class=n-a></a>Deckers IE, Janse IC, van der Zee HH, <i> et al.</i>: Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study. <i>J Am Acad Dermatol.</i> 2016; <b>75</b>(4): 755–759.e1. <a target=xrefwindow id=d28013e2274 href="http://www.ncbi.nlm.nih.gov/pubmed/27453539">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2277 href="http://dx.doi.org/10.1016/j.jaad.2016.04.067">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d28013e2286 class=n-a></a>Revuz JE, Jemec GB: Diagnosing Hidradenitis Suppurativa. <i>Dermatol Clin.</i> 2016; <b>34</b>(1): 1–5. <a target=xrefwindow id=d28013e2294 href="http://www.ncbi.nlm.nih.gov/pubmed/26617351">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2297 href="http://dx.doi.org/10.1016/j.det.2015.08.009">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d28013e2306 class=n-a></a>Moriarty B, Pink A, Creamer D, <i> et al.</i>: Hidradenitis suppurativa fulminans: a clinically distinct phenotype? <i>Br J Dermatol.</i> 2014; <b>171</b>(6): 1576–8. <a target=xrefwindow id=d28013e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/24890903">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2320 href="http://dx.doi.org/10.1111/bjd.13147">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d28013e2329 class=n-a></a>Frew JW, Vekic DA, Woods J, <i> et al.</i>: Phenotypic heterogeneity implies heterogeneous pathogenic pathways in hidradenitis suppurativa. <i>Exp Dermatol.</i> 2015; <b>24</b>(5): 338–9. <a target=xrefwindow id=d28013e2340 href="http://www.ncbi.nlm.nih.gov/pubmed/25644609">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2343 href="http://dx.doi.org/10.1111/exd.12648">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817103"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2353 class=n-a></a>Xu H, Xiao X, Hui Y, <i> et al.</i>: Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa). <i>Br J Dermatol.</i> 2016; <b>174</b>(4): 927–9. <a target=xrefwindow id=d28013e2364 href="http://www.ncbi.nlm.nih.gov/pubmed/26522179">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2367 href="http://dx.doi.org/10.1111/bjd.14268">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817103">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725107476"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2380 class=n-a></a>Canoui-Poitrine F, Le Thuaut A, Revuz JE, <i> et al.</i>: Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. <i>J Invest Dermatol.</i> 2013; <b>133</b>(6): 1506–11. <a target=xrefwindow id=d28013e2391 href="http://www.ncbi.nlm.nih.gov/pubmed/23235532">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2394 href="http://dx.doi.org/10.1038/jid.2012.472">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725107476">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718559053"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2407 class=n-a></a>Strowig T, Henao-Mejia J, Elinav E, <i> et al.</i>: Inflammasomes in health and disease. <i>Nature.</i> 2012; <b>481</b>(7381): 278–86. <a target=xrefwindow id=d28013e2418 href="http://www.ncbi.nlm.nih.gov/pubmed/22258606">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2421 href="http://dx.doi.org/10.1038/nature10759">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718559053">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d28013e2434 class=n-a></a>Marzano AV, Trevisan V, Gattorno M, <i> et al.</i>: Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the <i>PSTPIP1</i> gene. <i>JAMA Dermatol.</i> 2013; <b>149</b>(6): 762–4. <a target=xrefwindow id=d28013e2448 href="http://www.ncbi.nlm.nih.gov/pubmed/23571383">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2452 href="http://dx.doi.org/10.1001/jamadermatol.2013.2907">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717648069"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2461 class=n-a></a>Braun-Falco M, Kovnerystyy O, Lohse P, <i> et al.</i>: Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. <i>J Am Acad Dermatol.</i> 2012; <b>66</b>(3): 409–15. <a target=xrefwindow id=d28013e2472 href="http://www.ncbi.nlm.nih.gov/pubmed/21745697">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2475 href="http://dx.doi.org/10.1016/j.jaad.2010.12.025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717648069">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5680962"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2488 class=n-a></a>Wang B, Yang W, Wen W, <i> et al.</i>: Gamma-secretase gene mutations in familial acne inversa. <i>Science.</i> 2010; <b>330</b>(6007): 1065. <a target=xrefwindow id=d28013e2499 href="http://www.ncbi.nlm.nih.gov/pubmed/20929727">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2502 href="http://dx.doi.org/10.1126/science.1196284">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5680962">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d28013e2516 class=n-a></a>Prens E, Deckers I: Pathophysiology of hidradenitis suppurativa: An update. <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(5 Suppl 1): S8–11. <a target=xrefwindow id=d28013e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/26470623">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2527 href="http://dx.doi.org/10.1016/j.jaad.2015.07.045">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d28013e2536 class=n-a></a>Nomura Y, Nomura T, Suzuki S, <i> et al.</i>: A novel <i>NCSTN</i> mutation alone may be insufficient for the development of familial hidradenitis suppurativa. <i>J Dermatol Sci.</i> 2014; <b>74</b>(2): 180–2. <a target=xrefwindow id=d28013e2550 href="http://www.ncbi.nlm.nih.gov/pubmed/24581508">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2554 href="http://dx.doi.org/10.1016/j.jdermsci.2014.01.013">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725853850"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2563 class=n-a></a>Xiao X, He Y, Li C, <i> et al.</i>: Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3-kinase/AKT signalling pathways. <i>Br J Dermatol.</i> 2016; <b>174</b>(3): 522–32. <a target=xrefwindow id=d28013e2574 href="http://www.ncbi.nlm.nih.gov/pubmed/26473517">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2577 href="http://dx.doi.org/10.1111/bjd.14223">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725853850">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817104"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2590 class=n-a></a>Duchatelet S, Miskinyte S, Join-Lambert O, <i> et al.</i>: First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome. <i>Br J Dermatol.</i> 2015; <b>173</b>(2): 610–2. <a target=xrefwindow id=d28013e2601 href="http://www.ncbi.nlm.nih.gov/pubmed/25601011">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2604 href="http://dx.doi.org/10.1111/bjd.13668">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817104">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725312313"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2617 class=n-a></a>Deckers IE, van der Zee HH, Boer J, <i> et al.</i>: Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. <i>J Am Acad Dermatol.</i> 2015; <b>72</b>(3): 485–8. <a target=xrefwindow id=d28013e2628 href="http://www.ncbi.nlm.nih.gov/pubmed/25582541">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2631 href="http://dx.doi.org/10.1016/j.jaad.2014.11.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725312313">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d28013e2644 class=n-a></a>Vekic DA, Frew JW, Woods J, <i> et al.</i>: Adopting the orphan: The importance of recognising hidradenitis suppurativa as a systemic auto-inflammatory disease. <i>Australas J Dermatol.</i> 2016; <b>57</b>(1): 69–70. <a target=xrefwindow id=d28013e2655 href="http://www.ncbi.nlm.nih.gov/pubmed/26820785">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2658 href="http://dx.doi.org/10.1111/ajd.12287">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d28013e2668 class=n-a></a>Kurayev A, Ashkar H, Saraiya A, <i> et al.</i>: Hidradenitis Suppurativa: Review of the Pathogenesis and Treatment. <i>J Drugs Dermatol.</i> 2016; <b>15</b>(8): 1017–22. <a target=xrefwindow id=d28013e2679 href="http://www.ncbi.nlm.nih.gov/pubmed/27538005">PubMed Abstract </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d28013e2688 class=n-a></a>van der Zee HH, de Ruiter L, Boer J, <i> et al.</i>: Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. <i>Br J Dermatol.</i> 2012; <b>166</b>(1): 98–106. <a target=xrefwindow id=d28013e2699 href="http://www.ncbi.nlm.nih.gov/pubmed/21929531">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2702 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10643.x">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724196804"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2711 class=n-a></a>Danby FW, Jemec GB, Marsch WCh, <i> et al.</i>: Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. <i>Br J Dermatol.</i> 2013; <b>168</b>(5): 1034–9. <a target=xrefwindow id=d28013e2722 href="http://www.ncbi.nlm.nih.gov/pubmed/23320858">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2725 href="http://dx.doi.org/10.1111/bjd.12233">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724196804">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817105"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2738 class=n-a></a>Blok JL, Janse IC, Horváth B, <i> et al.</i>: Increased expression of integrin α6β4 in the basement membrane zone lining the sebaceous glands in hidradenitis suppurativa. <i>Acta Derm Venereol.</i> 2015; <b>95</b>(8): 994–6. <a target=xrefwindow id=d28013e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/26122397">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2752 href="http://dx.doi.org/10.2340/00015555-2186">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817105">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d28013e2765 class=n-a></a>Lima AL, Karl I, Giner T, <i> et al.</i>: Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. <i>Br J Dermatol.</i> 2016; <b>174</b>(3): 514–21. <a target=xrefwindow id=d28013e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/26436522">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2779 href="http://dx.doi.org/10.1111/bjd.14214">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726371218"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2788 class=n-a></a>Hotz C, Boniotto M, Guguin A, <i> et al.</i>: Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. <i>J Invest Dermatol.</i> 2016; <b>136</b>(9): 1768–80. <a target=xrefwindow id=d28013e2799 href="http://www.ncbi.nlm.nih.gov/pubmed/27206704">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2802 href="http://dx.doi.org/10.1016/j.jid.2016.04.036">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726371218">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d28013e2816 class=n-a></a>Kelly G, Prens EP: Inflammatory Mechanisms in Hidradenitis Suppurativa. <i>Dermatol Clin.</i> 2016; <b>34</b>(1): 51–8. <a target=xrefwindow id=d28013e2824 href="http://www.ncbi.nlm.nih.gov/pubmed/26617358">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2827 href="http://dx.doi.org/10.1016/j.det.2015.08.004">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d28013e2836 class=n-a></a>Jemec GB: Hidradenitis suppurativa and immune dysregulation. <i>Br J Dermatol.</i> 2012; <b>166</b>(2): 237–8. <a target=xrefwindow id=d28013e2844 href="http://www.ncbi.nlm.nih.gov/pubmed/22268854">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2847 href="http://dx.doi.org/10.1111/j.1365-2133.2012.10802.x">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1116313"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2856 class=n-a></a>Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, <i> et al.</i>: Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. <i>Br J Dermatol.</i> 2007; <b>156</b>(1): 51–6. <a target=xrefwindow id=d28013e2867 href="http://www.ncbi.nlm.nih.gov/pubmed/17199566">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2870 href="http://dx.doi.org/10.1111/j.1365-2133.2006.07556.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1116313">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724197501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2883 class=n-a></a>van der Zee HH, de Ruiter L, van den Broecke DG, <i> et al.</i>: Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. <i>Br J Dermatol.</i> 2011; <b>164</b>(6): 1292–8. <a target=xrefwindow id=d28013e2894 href="http://www.ncbi.nlm.nih.gov/pubmed/21332464">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2897 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10254.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724197501">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d28013e2910 class=n-a></a>Mozeika E, Pilmane M, Nürnberg BM, <i> et al.</i>: Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. <i>Acta Derm Venereol.</i> 2013; <b>93</b>(3): 301–4. <a target=xrefwindow id=d28013e2921 href="http://www.ncbi.nlm.nih.gov/pubmed/23096596">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2924 href="http://dx.doi.org/10.2340/00015555-1492">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d28013e2933 class=n-a></a>Kelly G, Hughes R, McGarry T, <i> et al.</i>: Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. <i>Br J Dermatol.</i> 2015; <b>173</b>(6): 1431–9. <a target=xrefwindow id=d28013e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/26282467">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2947 href="http://dx.doi.org/10.1111/bjd.14075">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d28013e2957 class=n-a></a>Kanni T, Tzanetakou V, Savva A, <i> et al.</i>: Compartmentalized Cytokine Responses in Hidradenitis Suppurativa. <i>PLoS One.</i> 2015; <b>10</b>(6): e0130522. <a target=xrefwindow id=d28013e2968 href="http://www.ncbi.nlm.nih.gov/pubmed/26091259">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2971 href="http://dx.doi.org/10.1371/journal.pone.0130522">Publisher Full Text </a> | <a target=xrefwindow id=d28013e2975 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4474720">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/721060825"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e2984 class=n-a></a>Schlapbach C, Hänni T, Yawalkar N, <i> et al.</i>: Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2011; <b>65</b>(4): 790–8. <a target=xrefwindow id=d28013e2995 href="http://www.ncbi.nlm.nih.gov/pubmed/21641076">PubMed Abstract </a> | <a target=xrefwindow id=d28013e2998 href="http://dx.doi.org/10.1016/j.jaad.2010.07.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/721060825">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d28013e3011 class=n-a></a>Dréno B, Khammari A, Brocard A, <i> et al.</i>: Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. <i>Arch Dermatol.</i> 2012; <b>148</b>(2): 182–6. <a target=xrefwindow id=d28013e3022 href="http://www.ncbi.nlm.nih.gov/pubmed/22004878">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3025 href="http://dx.doi.org/10.1001/archdermatol.2011.315">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d28013e3034 class=n-a></a>Speeckaert R, Lambert J, Grine L, <i> et al.</i>: The many faces of interleukin-17 in inflammatory skin diseases. <i>Br J Dermatol.</i> 2016; <b>175</b>(5): 892–901. <a target=xrefwindow id=d28013e3045 href="http://www.ncbi.nlm.nih.gov/pubmed/27117954">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3048 href="http://dx.doi.org/10.1111/bjd.14703">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725996464"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3057 class=n-a></a>Blok JL, Li K, Brodmerkel C, <i> et al.</i>: Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. <i>Br J Dermatol.</i> 2016; <b>174</b>(4): 839–46. <a target=xrefwindow id=d28013e3068 href="http://www.ncbi.nlm.nih.gov/pubmed/26641739">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3071 href="http://dx.doi.org/10.1111/bjd.14338">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725996464">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725944298"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3084 class=n-a></a>Tzanetakou V, Kanni T, Giatrakou S, <i> et al.</i>: Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. <i>JAMA Dermatol.</i> 2016; <b>152</b>(1): 52–9. <a target=xrefwindow id=d28013e3095 href="http://www.ncbi.nlm.nih.gov/pubmed/26579854">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3098 href="http://dx.doi.org/10.1001/jamadermatol.2015.3903">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725944298">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817107"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3112 class=n-a></a>Xu H, Xiao X, He Y, <i> et al.</i>: Increased serum interleukin-6 levels in patients with hidradenitis suppurativa. <i>Postepy Dermatol Alergol.</i> 2017; <b>34</b>(1): 82–4. <a target=xrefwindow id=d28013e3123 href="http://www.ncbi.nlm.nih.gov/pubmed/28261036">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3126 href="http://dx.doi.org/10.5114/ada.2017.65626">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3130 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5329110">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817107">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817109"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3143 class=n-a></a>Montaudié H, Seitz-Polski B, Cornille A, <i> et al.</i>: Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(1): 156–8. <a target=xrefwindow id=d28013e3154 href="http://www.ncbi.nlm.nih.gov/pubmed/27986139">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3157 href="http://dx.doi.org/10.1016/j.jaad.2016.08.036">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817109">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724197184"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3170 class=n-a></a>van der Zee HH, Laman JD, de Ruiter L, <i> et al.</i>: Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an <i>in situ</i> and <i>ex vivo</i> study. <i>Br J Dermatol.</i> 2012; <b>166</b>(2): 298–305. <a target=xrefwindow id=d28013e3188 href="http://www.ncbi.nlm.nih.gov/pubmed/22013960">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3191 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10698.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724197184">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726638680"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3204 class=n-a></a>Kimball AB, Okun MM, Williams DA, <i> et al.</i>: Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. <i>N Engl J Med.</i> 2016; <b>375</b>(5): 422–34. <a target=xrefwindow id=d28013e3215 href="http://www.ncbi.nlm.nih.gov/pubmed/27518661">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3218 href="http://dx.doi.org/10.1056/NEJMoa1504370">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726638680">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1162793"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3231 class=n-a></a>Schlapbach C, Yawalkar N, Hunger RE: Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. <i>J Am Acad Dermatol.</i> 2009; <b>61</b>(1): 58–65. <a target=xrefwindow id=d28013e3239 href="http://www.ncbi.nlm.nih.gov/pubmed/19249126">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3242 href="http://dx.doi.org/10.1016/j.jaad.2008.12.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1162793">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8237964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3255 class=n-a></a>Wolk K, Warszawska K, Hoeflich C, <i> et al.</i>: Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. <i>J Immunol.</i> 2011; <b>186</b>(2): 1228–39. <a target=xrefwindow id=d28013e3266 href="http://www.ncbi.nlm.nih.gov/pubmed/21148041">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3269 href="http://dx.doi.org/10.4049/jimmunol.0903907">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8237964">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726176758"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3283 class=n-a></a>Hessam S, Sand M, Skrygan M, <i> et al.</i>: Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients. <i>J Dermatol Sci.</i> 2016; <b>82</b>(3): 166–74. <a target=xrefwindow id=d28013e3294 href="http://www.ncbi.nlm.nih.gov/pubmed/26917346">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3297 href="http://dx.doi.org/10.1016/j.jdermsci.2016.02.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726176758">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727152955"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3310 class=n-a></a>Hessam S, Sand M, Skrygan M, <i> et al.</i>: Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. <i>Inflammation.</i> 2017; <b>40</b>(2): 464–72. <a target=xrefwindow id=d28013e3321 href="http://www.ncbi.nlm.nih.gov/pubmed/28028756">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3324 href="http://dx.doi.org/10.1007/s10753-016-0492-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727152955">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d28013e3337 class=n-a></a>Hannigan GD, Grice EA: Microbial ecology of the skin in the era of metagenomics and molecular microbiology. <i>Cold Spring Harb Perspect Med.</i> 2013; <b>3</b>(12): a015362. <a target=xrefwindow id=d28013e3345 href="http://www.ncbi.nlm.nih.gov/pubmed/24296350">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3348 href="http://dx.doi.org/10.1101/cshperspect.a015362">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3351 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3839604">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d28013e3360 class=n-a></a>Ring HC, Emtestam L: The Microbiology of Hidradenitis Suppurativa. <i>Dermatol Clin.</i> 2016; <b>34</b>(1): 29–35. <a target=xrefwindow id=d28013e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/26617355">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3371 href="http://dx.doi.org/10.1016/j.det.2015.08.010">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726371219"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3380 class=n-a></a>Thomas C, Rodby KA, Thomas J, <i> et al.</i>: Recalcitrant Hidradenitis Suppurativa: An Investigation of Demographics, Surgical Management, Bacterial Isolates, Pharmacologic Intervention, and Patient-reported Health Outcomes. <i>Am Surg.</i> 2016; <b>82</b>(4): 362–8. <a target=xrefwindow id=d28013e3391 href="http://www.ncbi.nlm.nih.gov/pubmed/27097631">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726371219">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725232917"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3404 class=n-a></a>Jahns AC, Killasli H, Nosek D, <i> et al.</i>: Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. <i>APMIS.</i> 2014; <b>122</b>(9): 804–9. <a target=xrefwindow id=d28013e3415 href="http://www.ncbi.nlm.nih.gov/pubmed/24475943">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3418 href="http://dx.doi.org/10.1111/apm.12220">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725232917">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d28013e3432 class=n-a></a>Guet-Revillet H, Coignard-Biehler H, Jais JP, <i> et al.</i>: Bacterial pathogens associated with hidradenitis suppurativa, France. <i>Emerging Infect Dis.</i> 2014; <b>20</b>(12): 1990–8. <a target=xrefwindow id=d28013e3443 href="http://www.ncbi.nlm.nih.gov/pubmed/25418454">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3446 href="http://dx.doi.org/10.3201/eid2012.140064">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3450 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4257786">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726679327"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3459 class=n-a></a>Ring HC, Bay L, Nilsson M, <i> et al.</i>: Bacterial biofilm in chronic lesions of hidradenitis suppurativa. <i>Br J Dermatol.</i> 2017; <b>176</b>(4): 993–1000. <a target=xrefwindow id=d28013e3470 href="http://www.ncbi.nlm.nih.gov/pubmed/27564400">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3473 href="http://dx.doi.org/10.1111/bjd.15007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726679327">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d28013e3486 class=n-a></a>Dowd SE, Sun Y, Smith E, <i> et al.</i>: Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. <i>J Wound Care.</i> 2009; <b>18</b>(12): 508, 510–12. <a target=xrefwindow id=d28013e3497 href="http://www.ncbi.nlm.nih.gov/pubmed/20081576">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3500 href="http://dx.doi.org/10.12968/jowc.2009.18.12.45608">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726432530"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3509 class=n-a></a>Okoye GA, Vlassova N, Olowoyeye O, <i> et al.</i>: Bacterial biofilm in acute lesions of hidradenitis suppurativa. <i>Br J Dermatol.</i> 2017; <b>176</b>(1): 241–3. <a target=xrefwindow id=d28013e3520 href="http://www.ncbi.nlm.nih.gov/pubmed/27291084">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3523 href="http://dx.doi.org/10.1111/bjd.14805">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726432530">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d28013e3536 class=n-a></a>Stoodley P: Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa. <i>Br J Dermatol.</i> 2017; <b>176</b>(4): 855–6. <a target=xrefwindow id=d28013e3544 href="http://www.ncbi.nlm.nih.gov/pubmed/28418126">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3547 href="http://dx.doi.org/10.1111/bjd.15256">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d28013e3556 class=n-a></a>Hurley H: Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. <i>Dermatologic Surgery.</i> 1989; <b>133</b>: 1506–11</span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d28013e3572 class=n-a></a>Hessam S, Sand M, Gambichler T, <i> et al.</i>: Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(6): 998–1005. <a target=xrefwindow id=d28013e3583 href="http://www.ncbi.nlm.nih.gov/pubmed/26410359">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3586 href="http://dx.doi.org/10.1016/j.jaad.2015.08.052">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d28013e3595 class=n-a></a>Kimball AB, Sobell JM, Zouboulis CC, <i> et al.</i>: HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study. <i>J Eur Acad Dermatol Venereol.</i> 2016; <b>30</b>(6): 989–94. <a target=xrefwindow id=d28013e3606 href="http://www.ncbi.nlm.nih.gov/pubmed/26201313">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3609 href="http://dx.doi.org/10.1111/jdv.13216">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5034809">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718141499"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3622 class=n-a></a>Wortsman X, Moreno C, Soto R, <i> et al.</i>: Ultrasound in-depth characterization and staging of hidradenitis suppurativa. <i>Dermatol Surg.</i> 2013; <b>39</b>(12): 1835–42. <a target=xrefwindow id=d28013e3633 href="http://www.ncbi.nlm.nih.gov/pubmed/24118433">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3636 href="http://dx.doi.org/10.1111/dsu.12329">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718141499">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d28013e3649 class=n-a></a>Kelekis NL, Efstathopoulos E, Balanika A, <i> et al.</i>: Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa. <i>Br J Dermatol.</i> 2010; <b>162</b>(6): 1400–2. <a target=xrefwindow id=d28013e3660 href="http://www.ncbi.nlm.nih.gov/pubmed/20184586">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3663 href="http://dx.doi.org/10.1111/j.1365-2133.2010.09710.x">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d28013e3672 class=n-a></a>Wortsman X, Wortsman J: Ultrasound Detection of Retained Hair Tracts in Hidradenitis Suppurativa. <i>Dermatol Surg.</i> 2015; <b>41</b>(7): 867–9. <a target=xrefwindow id=d28013e3680 href="http://www.ncbi.nlm.nih.gov/pubmed/26050213">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3683 href="http://dx.doi.org/10.1097/DSS.0000000000000388">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727817111"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3692 class=n-a></a>Gulliver W, Zouboulis CC, Prens E, <i> et al.</i>: Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. <i>Rev Endocr Metab Disord.</i> 2016; <b>17</b>(3): 343–51. <a target=xrefwindow id=d28013e3703 href="http://www.ncbi.nlm.nih.gov/pubmed/26831295">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3706 href="http://dx.doi.org/10.1007/s11154-016-9328-5">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5156664">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727817111">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d28013e3724 class=n-a></a>Bettoli V, Join-Lambert O, Nassif A: Antibiotic Treatment of Hidradenitis Suppurativa. <i>Dermatol Clin.</i> 2016; <b>34</b>(1): 81–9. <a target=xrefwindow id=d28013e3732 href="http://www.ncbi.nlm.nih.gov/pubmed/26617361">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3735 href="http://dx.doi.org/10.1016/j.det.2015.08.013">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d28013e3744 class=n-a></a>Fischer AH, Haskin A, Okoye GA: Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(2): 309–313.e2. <a target=xrefwindow id=d28013e3752 href="http://www.ncbi.nlm.nih.gov/pubmed/27742173">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3755 href="http://dx.doi.org/10.1016/j.jaad.2016.08.001">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3764 class=n-a></a>Kimball AB, Kerdel F, Adams D, <i> et al.</i>: Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. <i>Ann Intern Med.</i> 2012; <b>157</b>(12): 846–55. <a target=xrefwindow id=d28013e3775 href="http://www.ncbi.nlm.nih.gov/pubmed/23247938">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3778 href="http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969639">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d28013e3791 class=n-a></a>Amano M, Grant A, Kerdel FA: A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. <i>Int J Dermatol.</i> 2010; <b>49</b>(8): 950–5. <a target=xrefwindow id=d28013e3799 href="http://www.ncbi.nlm.nih.gov/pubmed/21128923">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3802 href="http://dx.doi.org/10.1111/j.1365-4632.2010.04545.x">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d28013e3811 class=n-a></a>Sullivan TP, Welsh E, Kerdel FA, <i> et al.</i>: Infliximab for hidradenitis suppurativa. <i>Br J Dermatol.</i> 2003; <b>149</b>(5): 1046–9. <a target=xrefwindow id=d28013e3822 href="http://www.ncbi.nlm.nih.gov/pubmed/14632813">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3825 href="http://dx.doi.org/10.1111/j.1365-2133.2003.05663.x">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d28013e3834 class=n-a></a>Brunasso AM, Delfino C, Massone C: Hidradenitis suppurativa: are tumour necrosis factor-alpha blockers the ultimate alternative? <i>Br J Dermatol.</i> 2008; <b>159</b>(3): 761–3. <a target=xrefwindow id=d28013e3842 href="http://www.ncbi.nlm.nih.gov/pubmed/18627370">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3845 href="http://dx.doi.org/10.1111/j.1365-2133.2008.08735.x">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2567956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3855 class=n-a></a>Grant A, Gonzalez T, Montgomery MO, <i> et al.</i>: Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. <i>J Am Acad Dermatol.</i> 2010; <b>62</b>(2): 205–17. <a target=xrefwindow id=d28013e3866 href="http://www.ncbi.nlm.nih.gov/pubmed/20115947">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3869 href="http://dx.doi.org/10.1016/j.jaad.2009.06.050">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2567956">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d28013e3882 class=n-a></a>Moul DK, Korman NJ: The cutting edge. Severe hidradenitis suppurativa treated with adalimumab. <i>Arch Dermatol.</i> 2006; <b>142</b>(9): 1110–2. <a target=xrefwindow id=d28013e3890 href="http://www.ncbi.nlm.nih.gov/pubmed/16982997">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3893 href="http://dx.doi.org/10.1001/archderm.142.9.1110">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d28013e3902 class=n-a></a>Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, <i> et al.</i>: An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. <i>Br J Dermatol.</i> 2008; <b>158</b>(3): 567–72. <a target=xrefwindow id=d28013e3913 href="http://www.ncbi.nlm.nih.gov/pubmed/18076705">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3916 href="http://dx.doi.org/10.1111/j.1365-2133.2007.08372.x">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d28013e3925 class=n-a></a>Adams DR, Yankura JA, Fogelberg AC, <i> et al.</i>: Treatment of hidradenitis suppurativa with etanercept injection. <i>Arch Dermatol.</i> 2010; <b>146</b>(5): 501–4. <a target=xrefwindow id=d28013e3936 href="http://www.ncbi.nlm.nih.gov/pubmed/20479297">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3939 href="http://dx.doi.org/10.1001/archdermatol.2010.72">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d28013e3948 class=n-a></a>Federici S, Martini A, Gattorno M: The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases. <i>Front Immunol.</i> 2013; <b>4</b>: 351. <a target=xrefwindow id=d28013e3956 href="http://www.ncbi.nlm.nih.gov/pubmed/24198817">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3959 href="http://dx.doi.org/10.3389/fimmu.2013.00351">Publisher Full Text </a> | <a target=xrefwindow id=d28013e3962 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3814084">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d28013e3971 class=n-a></a>Leslie KS, Tripathi SV, Nguyen TV, <i> et al.</i>: An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2014; <b>70</b>(2): 243–51. <a target=xrefwindow id=d28013e3982 href="http://www.ncbi.nlm.nih.gov/pubmed/24314876">PubMed Abstract </a> | <a target=xrefwindow id=d28013e3985 href="http://dx.doi.org/10.1016/j.jaad.2013.09.044">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725934324"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e3995 class=n-a></a>Join-Lambert O, Coignard-Biehler H, Jais JP, <i> et al.</i>: Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. <i>J Antimicrob Chemother.</i> 2016; <b>71</b>(2): 513–20. <a target=xrefwindow id=d28013e4006 href="http://www.ncbi.nlm.nih.gov/pubmed/26565016">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4009 href="http://dx.doi.org/10.1093/jac/dkv361">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725934324">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718091430"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4022 class=n-a></a>Verdolini R, Clayton N, Smith A, <i> et al.</i>: Metformin for the treatment of hidradenitis suppurativa: a little help along the way. <i>J Eur Acad Dermatol Venereol.</i> 2013; <b>27</b>(9): 1101–8. <a target=xrefwindow id=d28013e4033 href="http://www.ncbi.nlm.nih.gov/pubmed/22882365">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4036 href="http://dx.doi.org/10.1111/j.1468-3083.2012.04668.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718091430">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d28013e4049 class=n-a></a>Lim ZV, Oon HH: Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities. <i>Ann Dermatol.</i> 2016; <b>28</b>(2): 147–51. <a target=xrefwindow id=d28013e4057 href="http://www.ncbi.nlm.nih.gov/pubmed/27081259">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4060 href="http://dx.doi.org/10.5021/ad.2016.28.2.147">Publisher Full Text </a> | <a target=xrefwindow id=d28013e4063 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4828375">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d28013e4072 class=n-a></a>van der Zee HH, Prens EP: The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa. <i>Dermatology.</i> 2011; <b>223</b>(2): 169–73. <a target=xrefwindow id=d28013e4080 href="http://www.ncbi.nlm.nih.gov/pubmed/21997700">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4083 href="http://dx.doi.org/10.1159/000332846">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727170513"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4092 class=n-a></a>Armyra K, Kouris A, Markantoni V, <i> et al.</i>: Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients. <i>Int J Dermatol.</i> 2017; <b>56</b>(3): 346–50. <a target=xrefwindow id=d28013e4103 href="http://www.ncbi.nlm.nih.gov/pubmed/28054351">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4106 href="http://dx.doi.org/10.1111/ijd.13428">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727170513">F1000 Recommendation</a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726985760"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4119 class=n-a></a>Lee A, Fischer G: A case series of 20 women with hidradenitis suppurativa treated with spironolactone. <i>Australas J Dermatol.</i> 2015; <b>56</b>(3): 192–6. <a target=xrefwindow id=d28013e4127 href="http://www.ncbi.nlm.nih.gov/pubmed/26080895">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4130 href="http://dx.doi.org/10.1111/ajd.12362">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726985760">F1000 Recommendation</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d28013e4144 class=n-a></a>Wolcott R: Disrupting the biofilm matrix improves wound healing outcomes. <i>J Wound Care.</i> 2015; <b>24</b>(8): 366–71. <a target=xrefwindow id=d28013e4152 href="http://www.ncbi.nlm.nih.gov/pubmed/26562379">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4155 href="http://dx.doi.org/10.12968/jowc.2015.24.8.366">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726815822"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4164 class=n-a></a>Riis PT, Boer J, Prens EP, <i> et al.</i>: Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series. <i>J Am Acad Dermatol.</i> 2016; <b>75</b>(6): 1151–5. <a target=xrefwindow id=d28013e4175 href="http://www.ncbi.nlm.nih.gov/pubmed/27692735">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4178 href="http://dx.doi.org/10.1016/j.jaad.2016.06.049">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726815822">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726815821"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4191 class=n-a></a>Denny G, Anadkat MJ: The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study. <i>J Am Acad Dermatol.</i> 2017; <b>76</b>(1): 54–9. <a target=xrefwindow id=d28013e4199 href="http://www.ncbi.nlm.nih.gov/pubmed/27692736">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4202 href="http://dx.doi.org/10.1016/j.jaad.2016.07.041">Publisher Full Text </a> | <a target=xrefwindow id=d28013e4205 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5391674">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726815821">F1000 Recommendation</a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d28013e4218 class=n-a></a>Thomas CL, Gordon KD, Mortimer PS: Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. <i>Clin Exp Dermatol.</i> 2014; <b>39</b>(3): 315–7; quiz 317-8. <a target=xrefwindow id=d28013e4226 href="http://www.ncbi.nlm.nih.gov/pubmed/24635068">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4229 href="http://dx.doi.org/10.1111/ced.12269">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d28013e4238 class=n-a></a>Danby FW, Hazen PG, Boer J: New and traditional surgical approaches to hidradenitis suppurativa. <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(5 Suppl 1): S62–5. <a target=xrefwindow id=d28013e4246 href="http://www.ncbi.nlm.nih.gov/pubmed/26470619">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4249 href="http://dx.doi.org/10.1016/j.jaad.2015.07.043">Publisher Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d28013e4258 class=n-a></a>Jemec GB: Clinical practice. Hidradenitis suppurativa. <i>N Engl J Med.</i> 2012; <b>366</b>(2): 158–64. <a target=xrefwindow id=d28013e4266 href="http://www.ncbi.nlm.nih.gov/pubmed/22236226">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4269 href="http://dx.doi.org/10.1056/NEJMcp1014163">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d28013e4279 class=n-a></a>Danby FW: Commentary: unroofing for hidradenitis suppurativa, why and how. <i>J Am Acad Dermatol.</i> 2010; <b>63</b>(3): 481.e1–3. <a target=xrefwindow id=d28013e4287 href="http://www.ncbi.nlm.nih.gov/pubmed/20708473">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4290 href="http://dx.doi.org/10.1016/j.jaad.2010.01.033">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718251666"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4299 class=n-a></a>Blok JL, Spoo JR, Leeman FW, <i> et al.</i>: Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. <i>J Eur Acad Dermatol Venereol.</i> 2015; <b>29</b>(2): 379–82. <a target=xrefwindow id=d28013e4310 href="http://www.ncbi.nlm.nih.gov/pubmed/24460855">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4313 href="http://dx.doi.org/10.1111/jdv.12376">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718251666">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d28013e4326 class=n-a></a>Blok JL, Boersma M, Terra JB, <i> et al.</i>: Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients. <i>J Eur Acad Dermatol Venereol.</i> 2015; <b>29</b>(8): 1590–7. <a target=xrefwindow id=d28013e4337 href="http://www.ncbi.nlm.nih.gov/pubmed/25589154">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4340 href="http://dx.doi.org/10.1111/jdv.12952">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725881246"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4349 class=n-a></a>Mehdizadeh A, Hazen PG, Bechara FG, <i> et al.</i>: Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. <i>J Am Acad Dermatol.</i> 2015; <b>73</b>(5 Suppl 1): S70–7. <a target=xrefwindow id=d28013e4360 href="http://www.ncbi.nlm.nih.gov/pubmed/26470621">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4363 href="http://dx.doi.org/10.1016/j.jaad.2015.07.044">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725881246">F1000 Recommendation</a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d28013e4376 class=n-a></a>Humphries LS, Kueberuwa E, Beederman M, <i> et al.</i>: Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: A single-center experience. <i>J Plast Reconstr Aesthet Surg.</i> 2016; <b>69</b>(4): 554–66. <a target=xrefwindow id=d28013e4387 href="http://www.ncbi.nlm.nih.gov/pubmed/26785708">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4390 href="http://dx.doi.org/10.1016/j.bjps.2015.12.004">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d28013e4399 class=n-a></a>Tierney E, Mahmoud BH, Hexsel C, <i> et al.</i>: Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. <i>Dermatol Surg.</i> 2009; <b>35</b>(8): 1188–98. <a target=xrefwindow id=d28013e4410 href="http://www.ncbi.nlm.nih.gov/pubmed/19438670">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4413 href="http://dx.doi.org/10.1111/j.1524-4725.2009.01214.x">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5407956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4423 class=n-a></a>Xu LY, Wright DR, Mahmoud BH, <i> et al.</i>: Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. <i>Arch Dermatol.</i> 2011; <b>147</b>(1): 21–8. <a target=xrefwindow id=d28013e4434 href="http://www.ncbi.nlm.nih.gov/pubmed/20855672">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4437 href="http://dx.doi.org/10.1001/archdermatol.2010.245">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5407956">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722499788"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4450 class=n-a></a>Hazen PG, Hazen BP: Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. <i>Dermatol Surg.</i> 2010; <b>36</b>(2): 208–13. <a target=xrefwindow id=d28013e4458 href="http://www.ncbi.nlm.nih.gov/pubmed/20039918">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4461 href="http://dx.doi.org/10.1111/j.1524-4725.2009.01427.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722499788">F1000 Recommendation</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724199090"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4474 class=n-a></a>Madan V, Hindle E, Hussain W, <i> et al.</i>: Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. <i>Br J Dermatol.</i> 2008; <b>159</b>(6): 1309–14. <a target=xrefwindow id=d28013e4485 href="http://www.ncbi.nlm.nih.gov/pubmed/19036028">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4488 href="http://dx.doi.org/10.1111/j.1365-2133.2008.08932.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724199090">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725340826"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4501 class=n-a></a>Mikkelsen PR, Dufour DN, Zarchi K, <i> et al.</i>: Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. <i>Dermatol Surg.</i> 2015; <b>41</b>(2): 255–60. <a target=xrefwindow id=d28013e4512 href="http://www.ncbi.nlm.nih.gov/pubmed/25654196">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4515 href="http://dx.doi.org/10.1097/DSS.0000000000000264">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725340826">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d28013e4528 class=n-a></a>Nicholson CL, Hamzavi I, Ozog DM: Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO<sub>2</sub>) treatment after CO<sub>2</sub> excision of hidradenitis suppurativa axillary lesions: A case report. <i>JAAD Case Rep.</i> 2016; <b>2</b>(1): 4–6. <a target=xrefwindow id=d28013e4542 href="http://www.ncbi.nlm.nih.gov/pubmed/27051812">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4546 href="http://dx.doi.org/10.1016/j.jdcr.2015.11.001">Publisher Full Text </a> | <a target=xrefwindow id=d28013e4549 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4809444">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d28013e4558 class=n-a></a>Dessinioti C, Zisimou C, Tzanetakou V, <i> et al.</i>: Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up. <i>Clin Exp Dermatol.</i> 2016; <b>41</b>(8): 852–7. <a target=xrefwindow id=d28013e4569 href="http://www.ncbi.nlm.nih.gov/pubmed/27753139">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4572 href="http://dx.doi.org/10.1111/ced.12933">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d28013e4582 class=n-a></a>Join-Lambert O, Coignard H, Jais JP, <i> et al.</i>: Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. <i>Dermatology.</i> 2011; <b>222</b>(1): 49–58. <a target=xrefwindow id=d28013e4593 href="http://www.ncbi.nlm.nih.gov/pubmed/21109728">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4596 href="http://dx.doi.org/10.1159/000321716">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d28013e4605 class=n-a></a>van der Zee HH, Prens EP, Boer J: Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. <i>J Am Acad Dermatol.</i> 2010; <b>63</b>(3): 475–80. <a target=xrefwindow id=d28013e4613 href="http://www.ncbi.nlm.nih.gov/pubmed/20708472">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4616 href="http://dx.doi.org/10.1016/j.jaad.2009.12.018">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d28013e4625 class=n-a></a>Paradela S, Rodríguez-Lojo R, Fernández-Torres R, <i> et al.</i>: Long-term efficacy of infliximab in hidradenitis suppurativa. <i>J Dermatolog Treat.</i> 2012; <b>23</b>(4): 278–83. <a target=xrefwindow id=d28013e4636 href="http://www.ncbi.nlm.nih.gov/pubmed/22482700">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4639 href="http://dx.doi.org/10.3109/09546634.2012.683767">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727166217"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28013e4648 class=n-a></a>Kouris A, Platsidaki E, Christodoulou C, <i> et al.</i>: Quality of Life and Psychosocial Implications in Patients with Hidradenitis Suppurativa. <i>Dermatology.</i> 2016; <b>232</b>(6): 687–91. <a target=xrefwindow id=d28013e4659 href="http://www.ncbi.nlm.nih.gov/pubmed/28052274">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4662 href="http://dx.doi.org/10.1159/000453355">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727166217">F1000 Recommendation</a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d28013e4675 class=n-a></a>Holt-Lunstad J, Smith TB, Baker M: Loneliness and social isolation as risk factors for mortality: a meta-analytic review. <i>Perspect Psychol Sci.</i> 2015; <b>10</b>(2): 227–37. <a target=xrefwindow id=d28013e4683 href="http://www.ncbi.nlm.nih.gov/pubmed/25910392">PubMed Abstract </a> | <a target=xrefwindow id=d28013e4686 href="http://dx.doi.org/10.1177/1745691614568352">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jul 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1272/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1272/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Wayne State University School of Medicine, Detroit, MI, USA<br/> <sup>2</sup> Henry Ford Hospital Department of Dermatology, Detroit, MI, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1272/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Jul 2017, 6:1272 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11337.1">https://doi.org/10.12688/f1000research.11337.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Smith MK <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12238 data-id=11337 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11337.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1272/v1/pdf?article_uuid=6bd3d3d1-1fe1-4038-aebd-569b6ef2d94b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11337.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Smith MK, Nicholson CL, Parks-Miller A and Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts [version 1; peer review: 3 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1272 (<a href="https://doi.org/10.12688/f1000research.11337.1" target=_blank>https://doi.org/10.12688/f1000research.11337.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11337 id=mobile-track-article-signin-11337 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11337?target=/articles/6-1272/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12238 /> <input name=articleId type=hidden value=11337 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Robert Micheletti</strong>, Department of Dermatology and Department of Medicine, University of Pennsylvania, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Christopher Sayed</strong>, Department of Dermatology, The University of North Carolina at Chapel Hill, USA; UNC Dermatology and Skin Cancer Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Christopher Sayed has held roles with Abbvie Inc. as a speaker, Advisory Board Member and co-investigator. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Geoffrey David Cains</strong>, Department of Dermatology, University of New South Wales, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jul 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1272/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1272/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=24394-24624></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23057-22888></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=24395-24625></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1272/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Jul 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Robert Micheletti</strong>, Department of Dermatology and Department of Medicine, University of Pennsylvania, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Christopher Sayed</strong>, Department of Dermatology, The University of North Carolina at Chapel Hill, USA; UNC Dermatology and Skin Cancer Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Christopher Sayed has held roles with Abbvie Inc. as a speaker, Advisory Board Member and co-investigator. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Geoffrey David Cains</strong>, Department of Dermatology, University of New South Wales, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1272/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1272/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Hidradenitis suppurativa: an update on connecting...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1272/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1272/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1272/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Smith MK et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1272/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1272",
            templates : {
                twitter : "Hidradenitis suppurativa: an update on connecting the tracts. Smith MK et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1272/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Hidradenitis suppurativa: an update on connecting the tracts", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Hidradenitis suppurativa: an update on connecting the tracts", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11337/12238")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12238");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "24624": 0,
                           "24625": 0,
                           "22888": 0,
                           "24623": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "704c7813-25b7-4982-897d-aa240038d239";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1272.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1272.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1272.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1272.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1272.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>